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1 Introduction 
The fundamental role of transcription in regulating gene expression is well 
established. However, the importance of post-transcriptional mechanisms has been 
increasingly acknowledged only in recent decades. These mechanisms involve 
alternative splicing and mRNA editing, specific subcellular targeting of mature mRNA, 
translational regulation and posttranslational modifications of proteins (Hovland et 
al., 1996; Ashkenas, 1997; Macdonald, 2001; Routtenberg and Rekart, 2005; Xiao and 
Lee, 2010). Translational regulation plays a key role in controlling the process of protein 
synthesis (Merrick, 1992). It is fundamental for relatively basic mechanisms (e.g. 
mitosis) and the most complex biological functions (e.g. learning and cognition). The 
latter we just start to elucidate. 
1.1 The initiation phase of translation 
Most of the translational regulation occurs at the initiation phase. Probably due to 
this fact, the evolutionary mechanisms of initiation have diverged the most, allowing 
different organisms to adjust protein synthesis to their needs. Herein, the focus is put on 
5’ end-dependent mechanism of translation initiation in eukaryotes (Fig. 1-1). For 
simplicity reasons, several factors directly and indirectly involved in translation 
initiation were omitted. Modulation of translation efficiency in eukaryotes involves 
proteins, called eukaryotic translation initiation factors (eIFs) as well as proteins 
interacting with them and/or with mRNA. The magnitude of the regulation, as well as its 
direction (inhibition or activation), depends on the interplay between these proteins 
and mRNAs, as well as on auxiliary regulatory factors (i.e. protein kinases). Promotion of 
translation leads to recognition of the initiation codon and formation of the 48S complex 
(the complex of the S40 ribosomal subunit, initiation factors and mRNA) (Mendez and 
Richter, 2001; Jackson et al., 2010). A simplified scheme of translation initiation steps, 
leading to S48 complex formation is presented in Fig. 1-1. 
 
Fig. 1-1: “Canonical” 5’ end-dependent mechanisms of translation initiation in eukaryotes. 
Eukaryotic initiation factors eIF1, eIF1A, eIF2, eIF3, eIF4A, eIF4B, eIF4E, eIF4G, and eIF5 are labelled 1, 
1A, 2, 3, 4A, 4B, 4E, 4G, and 5, respectively; Met – methionyl-tRNA; m7G - 7-methyl guanine nucleotide 
(cap); PABP – Poly(A) Binding Protein; AUG – start codon (encoding methionine); 40S – small ribosomal 
subunit; (A)n – poly(A) tail. Adapted from Malys and McCarthy (2011). 
In cap-dependent translation initiation (shown in Fig. 1-1), most regulatory factors 
are nucleated around eIF-4A, eIF-4E and eIF-4G (together forming a cap-binding 
48S 
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complex eIF-4F) at the 5’end of mRNA. Assembly of eIF-4F facilitates binding to the S40 
ribosomal subunit, via eIF-3. eIF-3, in turn, recruits eIF-2-GTP-Met-tRNA to the complex 
and promotes ribosomal scanning of the start codon (Jackson et al., 2010). The detailed 
function of the initiation factors depicted on Fig. 1-1 is summarized in Tab. 1-1.  
Factor 
Number 
of subunits 
Function 
eIF-1 1 
Ensures the fidelity of initiation codon selection, promotes ribosomal 
scanning, stimulates binding of eIF2–GTP–Met-tRNAi to 40S subunits, prevents 
premature eIF5-induced hydrolysis of eIF2-bound GTP and Pi release 
eIF-1A 1 
Stimulates binding of eIF2–GTP–Met-tRNAi to 40S subunits and cooperates 
with eIF1 in promoting ribosomal scanning and initiation codon selection 
eIF-2 3 
Forms an eIF2–GTP–Met-tRNAi ternary complex that binds to the 40S subunit, 
thus mediating ribosomal recruitment of Met-tRNAi 
eIF-3 13 
Binds 40S subunits, eIF1, eIF4G and eIF5; stimulates binding of eIF2–GTP–
Met-tRNAi to 40S subunits; promotes attachment of 43S complexes to mRNA 
and subsequent scanning; possesses ribosome dissociation and anti-
association activities, preventing joining of 40S and 60S subunits 
eIF-4A 1 ATP-dependent RNA helicase 
eIF-4E 1 Binds to the 5′ cap structure of mRNA 
eIF-4G 1 
Binds eIF4E, eIF4A, eIF3, PABP, SLIP1 and mRNA and enhances the helicase 
activity of elF4A 
eIF-4F 3 
A cap-binding complex, comprising eIF4E, eIF4A and eIF4G, unwinds the 5′ 
proximal region of mRNA and mediates the attachment of 43S complexes to it, 
assists ribosomal complexes during scanning 
eIF-4B 1 An RNA-binding protein that enhances the helicase activity of eIF4A 
eIF-5 1 
A GTPase-activating protein, specific for GTP-bound eIF2, that induces 
hydrolysis of eIF2-bound GTP upon recognition of the initiation codon 
PABP 1 
Binds to the 3′ poly(A) tail of mRNA and eIF4G, enhances binding of eIF4F to 
the cap, might facilitate recruitment of recycled post-termination 40S subunits 
back to the 5′ end of mRNA 
Tab. 1-1: Selected translation initiation factors and their functions. PABP – Poly(A) Binding Protein 
(after Jackson et al., 2010). 
1.2 3’UTR-interacting proteins mediate mRNA  
sequence-specific translational regulation 
Translation of polyadenylated mRNAs is promoted by interaction of the poly(A) tail 
with the capped 5’end of the mRNA, facilitating the 48S complex formation (Fig. 1-1). 
This occurs via the Poly(A) Binding Protein (PABP) and involves physical interaction 
between eIF-4G and PABP (Tarun and Sachs, 1996). The resulting circularization of the 
mRNA structure (Fig. 1-2) leads to an increase in protein synthesis. Such circularization 
of transcripts may have at least three advantages, contributing to an increase in the 
overall translation efficacy: (i) promotion of reinitiation of translation at the 5’ end, as 
the 3’ end of mRNA is in close proximity, (ii) stabilization of the transcript due to 
simultaneous protection of both mRNA ends, (iii) prevention of translation of truncated 
transcripts (Johnstone and Lasko, 2001).  
Doctoral Thesis – Lech Kaczmarczyk Introduction 
-9- 
 
Fig. 1-2: Circular protein-RNA complexes. Atomic 
force microscopy visualization of circular, capped 
and polyadenylated double-stranded mRNAs in the 
presence of Poly(A) Binding Protein (PABP), eIF-4G 
and eIF-4E (after Wells et al., 1998). 
 
The binding of PABP to eIF-4F is not the only example of the interaction between        
3’ and 5’ mRNA ends. Protein factors interacting with mRNA in a sequence-specific 
manner can modulate synthesis of specific proteins by competing with the 5’mRNA end 
for PABP binding, by affecting its structural conformation, or by modulating the length 
of the poly(A) tail and thereby regulating the amount of PABP binding to it. This type of 
regulation involves non-canonical (i.e. required only in certain circumstances) auxiliary 
proteins, which by interacting with canonical (core) elements of the translational 
machinery, restrict the formation of the S43 complex (composed of a 40S subunit, eIF1, 
eIF1A, eIF3, eIF2–GTP–Metionyl-tRNA and probably eIF5) (Jackson et al., 2010). Such 
sequence-specific regulators of translation initiation are most often binding to the 3’UTR 
region of the mRNA and prevent interaction of PABP with the cap-binding complex 
either directly or via intermediate proteins (Fig. 1-3).  
 
Fig. 1-3: Circular model of translational inhibition by 3’UTR-interacting proteins. A sequence 
specific translational factor X binds to the 3’UTR of mRNA and either directly or via an intermediate 
protein Y, interacts with the cap-binding protein Z. This results in translational inhibition by preventing 
the assembly of the cap-binding complex (eIF-4E + eIF-4G + eIF-4A). After Jackson et al. (2010). 
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In Tab. 1-2, examples of proteins X, Y, and Z (from Fig. 1-3) in Xenopus laevis oocytes and 
Drosophila melanogaster embryos are shown.  
Organism mRNA Protein X Protein Y Protein Z 
Xenopus laevis 
(oocytes) 
Cyclin B1 
(and others) 
CPEB eIF-4E-T/Maskin eIF-4E1a/b 
Drosophila melanogaster 
(embryos) 
Nanos Smaug CUP eIF-4E1b 
Oskar Bruno CUP eIF-4E1b 
Caudal Bicoid Bicoid eIF-4E-HP 
Hauchback 
Nanos, Pumilio, 
and Brat 
Nanos, Pumilio, 
and Brat 
eIF-4E-HP 
Tab. 1-2: Translational regulation by 3’UTR-interacting proteins. Selected examples of proteins 
involved in translational regulation in the 3’UTR in Xenopus laevis oocytes and Drosophila melanogaster 
embryos. Protein homologues, performing the function of proteins X, Y and Z (from Fig. 1-3), were shown 
(proteins fulfilling the function of both, X and Y were highlighted in bold). After Jackson et al. (2010). 
1.3 Translational regulation: from development to 
synaptic plasticity and memory 
In animal development, the regulation of gene expression occurs preferentially at the 
translation level, when a quick response to environmental cues is crucial. For example, 
translation of a pool of maternal mRNAs in the oocyte (transcribed during oogenesis) is 
rapidly triggered upon fertilization. Later, during development, translational regulation 
allows for a precise spatiotemporal restriction of protein expression, required for 
proper embryonic patterning (Curtis et al., 1995; Tadros and Lipshitz, 2005). 
Translational regulation in development has been most extensively studied on two 
model organisms: Xenopus laevis (African clawed frog) and Drosophila melanogaster 
(Fruit fly). In both, it involves the regulation of Poly(A) tail length (Wilhelm and Smibert, 
2005; Richter and Lasko, 2011). However oocyte maturation and embryonic 
development are not the only processes where translation regulation plays a key role. 
Translational mechanisms are also involved in strictly somatic processes, e.g. iron 
homeostasis (Muckenthaler et al., 1998) or erythroid differentiation (Ostareck et al., 
2001). More recently, translational regulation has been shown critical for the 
functioning of the central nervous system (CNS). The increasing evolutionary 
complexity of animal nervous systems led to development of complex pre- and 
postsynaptic mechanisms, to allow appropriate responses to complex patterns of 
synaptic stimulation. These mechanisms are nowadays acknowledged as the basis for 
how the brain perceives and stores information (Kandel, 2001; Klann and Dever, 2004).  
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1.3.1 Translational regulation by the Cytoplasmic Polyadenylation 
Element Binding proteins 
The Cytoplasmic Polyadenylation Element Binding proteins (referred herein as CPEBs) 
are mRNA-binding translational factors. CPEBs in mammals comprise a family of four 
within-species paralogs, sharing considerable structural and functional similarities. All 
CPEBs contain an N-terminal regulatory domain (containing phosphorylation sites) and        
a   C-terminal RNA binding domain (RBD), containing a Zn2+ finger (ZiF) motif (Fig. 1-4).  
 
Fig. 1-4: Tertiary structure of CPEBs.  All four CPEBs expressed in mouse brain are structurally 
similar, consisting of an N-terminal regulatory domain (containing phosphorylation sites) and           
a C-terminal RBD containing a ZiF motif. 
On the basis of the RBD, CPEBs 2-4 can be regarded as a separate group, as they share 
more than 98% similarity in the amino acid sequence of their RBDs (Theis et al., 2003b). 
CPEBs bind to a conserved nucleotide sequence (cytoplasmic polyadenylation element, 
CPE) located in the 3’UTR of the target mRNAs, and generally repress translation, unless 
activated. The recognition consensus site for CPEBs is the uracil-rich sequence 
UUUUUAU. However, the sequence specificity of CPEBs is not strictly defined and 
alternative binding sites have been widely reported (Hake et al., 1998; Du and Richter, 
2005). In addition to oogenesis and embryonic development, they are involved in the 
control of cellular senescence, synaptic plasticity, memory and learning. Seven percent 
of brain mRNAs are estimated to be CPEB targets based on the presence of a CPE, 
although only a small fraction has been experimentally confirmed so far. 
1.4 Long term potentiation and synaptic plasticity 
As synaptic plasticity we understand the changes in the synaptic efficacy induced by 
varying patterns of neuronal activity. This unique quality of synaptic connections and 
their interplay with astrocytes seem to be the basis for how neural circuits modulate 
their own activity. It is neuronal plasticity that allows the brain to perform most, if not all 
of its higher functions, including cognitive ones. One form of synaptic plasticity, thought 
to be especially related to memory and learning, is long term potentiation (LTP) – a long 
lasting enhancement of synaptic efficacy. It represents an evolutionary conserved 
mechanism of memory storage (Kandel, 2001). The subcellular mechanisms of LTP 
formation remain to large extent unknown, however in recent years much progress has 
been made towards the delineation of how LTP is triggered and maintained, what 
proteins are involved in this process and how they interact with each other, allowing us 
to remember our own birthday date or significant events in our life. Depending on the 
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strength of the postsynaptic stimulation, we can distinguish an early phase of LTP (E-LTP), 
and a late phase of LTP (L-LTP). Unlike E-LTP, L-LTP requires new protein synthesis. Initial 
models suggested that synthesis of plasticity related proteins (PRPs) occurs in the cell body 
(together with the synthesis of other proteins) and these proteins are subsequently targeted 
specifically to the activated synapse(s). However, recent evidence suggest that protein 
synthesis occurs independently of transcription and be restricted to neuronal dendrites 
(reviewed by Klann and Dever, 2004). Moreover, the mechanisms involved are evolutionary 
conserved: long term facilitation (LTF), a long-term form of synaptic plasticity in Aplysia 
californica is mechanistically very similar to L-LTP in the mammalian hippocampus 
(Kandel, 2001). These processes are the cellular correlates of learning and memory. Herein, 
selected regulatory mechanisms of local protein synthesis in brain involving CPEB proteins 
are described. 
1.5 Subcellular mRNA targeting 
As early as in 1965 David Bodian spotted a striking relationship of nerve cell RNA 
with specific synaptic sites (Bodian, 1965). Later on, dendritic spines were found to 
contain polyribosomes (Steward and Levy, 1982). Since this early works, a large number 
of neuronal transcripts distributed in a polarized fashion has been identified (Eberwine 
et al., 2002). A genome-wide analysis of gene expression reveals that a significant 
number of messenger RNAs have a specific localization in neurons (Lein et al., 2007). 
Dendritically localized mRNA is involved in certain types of synaptic plasticity (Kang and 
Schuman, 1996; Huber et al., 2000; Jansen, 2001; Luscher and Huber, 2010). 
Particularly striking sub-regional differences in mRNA localization were observed for 
hippocampus and cerebellum. One of such dendrite-specific mRNA is the transcript 
encoding the alpha isoform of Ca2+/Calmodulin-dependent protein kinase II (CaMKII), 
a key player in synaptic plasticity and a CPEB target.  
1.6 CPEB in neural function 
Local translation is a key mechanism controlling protein homeostasis of the synapse, 
and thereby synaptic plasticity (Wu et al., 2007; Cajigas et al., 2010). The molecular 
mechanism of CPEB function in this process has been extensively discussed (Mendez 
and Richter, 2001; Richter, 2007). Nonetheless, still very little is known about the nature 
of interactions between CPEBs and other elements of translational machinery. Several 
proteins were shown to functionally interact with CPEB in mouse hippocampus. These 
includes Neuroguidin (Ngd), a protein repressing translation in a CPE-dependent 
manner in Xenopus oocytes (Jung et al., 2006). Importantly, neuroguidin is present in 
axon and dendrites, where it may have a function similar to maskin, with which it shares 
structural similarities. CPEB-1 also was shown to interact with the poly(A) polymerase 
Gld2 (Rouhana et al., 2005). Gld2 expression in mammalian brain is most abundant in 
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cognitive and emotional learning-associated areas, further showing involvement of 
translational regulation in learning and memory mechanisms (Rouhana et al., 2005). 
Other proteins which bind to CPEB and which are also present in neurons are the 
cleavage and polyadenylation specificity factor (CPSF), symplekin, and poly(A)-specific 
ribonuclease (PARN) (see Fig. 1-5). CPSF is a crucial factor, recognizing the AAUAAA 
hexanucleotide, which is required for pre-mRNA polyadenylation (Takagaki et al., 1990).  
 
Fig. 1-5: General scheme of translational regulation by CPEBs. Following splicing and RNA export,        
a ribonucleoprotein (RNP) complex is nucleated by CPEB. Two proteins involved, PARN (deadenylase) 
and Gld2 (poly(A) polymerase) are competing with each other, with PARN overriding Gld2 activity, 
leading to poly(A) tail shortening. After CPEB phosphorylation by Aurora A kinase, a conformational 
change expulses PARN from the complex and allows polyadenylation of the mRNA by Gld2, ultimately 
resulting in increase in protein expression. See also description in the text (after Richter, 2007). 
Symplekin is binding to CPSF and is a scaffold protein, serving as a nucleation factor 
for other members of the CPEB complex (Barnard et al., 2004). PARN is a deadenylating 
enzyme, overriding Gld2 polymerase activity (Copeland and Wormington, 2001). After 
CPEB phosphorylation by Aurora A kinase, a conformational change leads to expulsion 
of PARN from the complex, allowing Gld2-mediated polyadenylation, ultimately 
resulting in an increase of protein expression. Several other factors are directly or 
indirectly involved in CPE-mediated polyadenylation in Xenopus (reviewed by Radford 
et al., 2008). The most extensively studied function of CPEBs in neurons is sequestration 
of dendritic mRNAs, causing translational repression. Neuronal stimulation leads to 
activation of CPEBs, thereby leading to initiation of translation of plasticity-related 
proteins at the postsynaptic site (Fig. 1-6).  
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Fig. 1-6: Hypothetical scheme of CPEB function in neurons. Following N-methyl-D-aspartate (NMDA) 
receptor activation, kinases – Aurora and/or CaMKII (Atkins et al., 2005) – are activated and 
phosphorylate CPEB1. Phosphorylation stabilizes the Cleavage and Polyadenylation Specificity Factor 
(CPSF) on the AAUAAA hexanucleotide, which attracts poly(A) polymerase (PAP) to catalyze 
polyadenylation. Maskin dissociates from eIF4E (cap binding protein). eIF4G then binds eIF4E and 
initiates translation. Adapted from Klann & Dever (2004). 
One of the most intriguing examples of the neuronal function of CPEBs is their role in 
modulation of late-phase LTP, a phenomenon regarded as the cellular correlate of long 
term memory. As mentioned before, CPEBs primary function in neurons is the 
modulation of activity-dependent local protein synthesis in dendritic spines and, 
thereby, control of synaptic efficacy. One of the key players in synaptic plasticity is the 
CaMKII The rat CaMKII mRNA contains 2 CPE elements and is bound by CPEB-1 (Wu 
et al., 1998). In rat visual cortex, CaMKII is polyadenylated and upregulated following 
visual stimulation. Taken together, CPEB-1 may be involved in the plasticity of the visual 
cortex (Wu et al., 1998). CPEB-1 is also phosphorylated upon N-methyl-D-aspartate 
receptor (NMDA receptor, NMDA-R) activation, via Aurora and CaMKII kinase (Huang et 
al., 2002; Atkins et al., 2005).  NMDA-R is a major receptor of the neurotransmitter 
glutamate, involved in different forms of synaptic plasticity in most brain regions. 
Existence of a direct signalling pathway affirms the function of CPEB as synaptic 
modulator (Huang et al., 2002).  
CPEB-1 in neurons was shown to sequester microtubule associated protein 2 (MAP2) 
mRNA while it was transported to dendrites, via direct or indirect interaction with 
molecular motors of the kinesin and dynein families (Huang et al., 2003). Such 
sequestration would ensure temporal (NMDA-R activation) and spatial (dendritic 
spines) control of the translation of CPEB targets. 
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CPEB-1 was shown to bind amyloid-precursor-like protein 1 (APLP1), as well as related 
proteins, including amyloid precursor protein (APP) (Cao et al., 2005). APLP1 is a paralog of 
APP, directly associated with the Alzheimer’s disease pathology. Although it does not link 
CPEB directly to the pathology of Alzheimer’s, APLP1 may serve as a membrane anchor for 
the complex of CPEB and CPEB-interacting proteins. Membrane proximity could ensure 
efficient phosphorylation upon synaptic stimulation. 
Tissue plasminogen activator (tPA) – a serine protease produced in brain by neurons 
and microglia – is a key player in synaptic plasticity (Samson and Medcalf, 2006). tPA is 
also implicated in neurodegeneration following seizures in mouse brain (Tsirka et al., 
1995). In neurons, the production of tPA was demonstrated to be translationally 
regulated by CPEB-1 protein (Shin et al., 2004).  
In neuronal cultures, CPEB-3 represses the translation of the GluR2 subunit of the            
α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor (AMPA-R) 
(Huang et al., 2006) – a protein critical for many forms of synaptic plasticity (Jia et al., 1996; 
Bassani et al., 2009; Gainey et al., 2009). Several transgenic mice were generated to address 
CPEB function in vivo. In the CPEB-1 knockout (KO) mice, restricted deficits in long term 
potentiation (LTP) were observed (Alarcon et al., 2004). On the behavioral level, CPEB-1 KO 
mice show reduced hippocampal memory extinction (Berger-Sweeney et al., 2006). 
Overexpression of an N-terminally truncated mutant form of CPEB-1 (lacking regulatory 
phosphorylation sites), termed dominant-negative CPEB1-4 (DN-CPEB1-4), in principal 
neurons led to deficits in stimulation induced protein synthesis and L-LTP, LTP induced 
by repeated trains of TBS (theta-burst stimulation), which correlated with impaired 
spatial reference memory tested in the Morris Water Maze task (Theis et al., in revision). 
The latter finding is the first demonstration of target mRNA specificity overlap between 
CPEBs -2 to -4 and CPEB-1. Moreover, CPEB-3 translation might be regulated by CPEBs: 
CPEB-3 protein levels are strongly upregulated upon intraperitoneal kainate injection 
(Theis et al., 2003b). Such upregulation is not observed in DN-CPEB1-4 mice (Theis et al., in 
revision). In another in vivo model, mice overexpressing a kinase dead CPEB-1 mutant 
protein (mutations T171A and S177A) in Purkinje cells showed impaired cerebellar LTD 
and motor deficits (McEvoy et al., 2007).  
Other interesting insights into CPEB function in memory come from invertebrate 
research. Orb2, a Drosophila melanogaster homolog of CPEB-1 protein, is critical for 
long-term conditioning of male courtship behaviour (Keleman et al., 2007). Aplysia 
CPEB (ApCPEB), a homolog of mouse CPEB-3 in Aplysia californica, is required in long 
term facilitation (LTF) – the Aplysia correlate of long-term memory (Si et al., 2003; 
Miniaci et al., 2008; Si et al., 2010). 
Last but not least, CPEB-3 was found to play a role in memory formation in humans. 
In the intronic sequence of CPEB3 a self-cleaving ribozyme has been identified (Salehi-
Ashtiani et al., 2006). The polymorphic single nucleotide variation in sequence of this 
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ribozyme, influencing its enzymatic, self-cleaving activity, was related to the 
performance of human subjects in an episodic memory task (Vogler et al., 2009). 
1.7 CPEBs in glial function 
CPEB proteins in brain are not restricted to neurons – they are expressed by all major 
cell populations, including astrocytes, NG2 cells, and microglia. Given increasing importance 
of glial cells and neuron-glia communication, it is conceivable that CPEBs may play an 
important role in glial contribution to CNS signalling. Astrocytic CPEB-1 is involved in cell 
motility and migration, via translational regulation of the actin-binding protein -catenin 
(Jones et al., 2008). -catenin is a multifunctional protein, involved in cytoskeletal 
organization and cell signalling. In addition, neuronal targets of CPEBs may be (if present) 
likewise translationally regulated in glial cells. The AMPA-R subunit GluR2 might be an 
example, as it is expressed in NG2 glial cells. In the healthy brain, two subpopulations of 
cells with astroglial properties can be distinguished (Matthias et al., 2003). One 
subpopulation – GluT cells or bona fide astrocytes – display passive electrical properties and 
express glutamate transporter-1 (GLT-1) protein. The other – GluR cells – express 
functional GluR2 subunit-containing AMPA-Rs (Matthias et al., 2003) as well as GABA 
receptors (Jabs et al., 2005). The population of GluR cells is, at least in the hippocampus, to 
large extent overlapping with the so-called NG2 glial cells (Karram et al., 2008). In human 
subjects with Ammon’s Horn Sclerosis (pathological changes in the hippocampus often 
associated with temporal lobe epilepsy (TLE)) the GluT cells disappear (Hinterkeuser et al., 
2000). Interestingly, both GluR and GluT cells possessed GLT-1 mRNA, but only GluT cells 
expressed functional transporters. And both GluR2 and GLT-1 mRNAs have CPEs in their 
3’UTRs. It is therefore possible, that GLT-1 expression and, thereby, the cellular phenotype 
of glial populations is translationally regulated by CPEBs. Likewise, pathological alterations 
in epilepsy might occur, at least to a certain extent, on the translational level. Considering 
the reciprocal glutamatergic interaction of neurons and glial cells (Hansson and Ronnback, 
2003; Lin and Bergles, 2004), CPEBs in astrocytes might thereby modulate both, normal and 
epileptiform neuronal activity. Finally, in neurons, production of tPA was demonstrated to 
be translationally regulated by CPEB-1 protein (Shin et al., 2004). However, not the 
neuronal but the microglial tPA is critically involved in neurodegeneration following 
seizures in mouse brain (Siao et al., 2003). 
1.8 Transgenic approaches to study gene function 
To study protein function in brain in vivo, several gene manipulation strategies have 
been developed during the last decades. The idea dates back to the early work 
conducted by the three Nobel Prize laureates, Mario R. Capecchi, Sir Martin J. Evans, and 
Oliver Smithies, ultimately leading to establishment of targeted gene manipulation 
methods in mice (Evans and Kaufman, 1981; Thomas et al., 1986; Doetschman et al., 
1988; Capecchi, 2001).  
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1.8.1 Spatiotemporal control of gene deletion 
Currently, the most common system for the in vivo genetic manipulation is an 
unrestricted deletion (knock-out) or modification of a specific gene. This is achieved by 
homologous recombination following transfection of mouse embryonic stem (ES) cells, 
selection of homologously recombined ES cell clones, and injection of ES cells into mouse 
embryos of the blastocyst stage (Capecchi, 2001). This strategy, however, is not free of 
limitations, as it affects every process (and at all developmental stages) in which the 
studied gene (protein) plays a role. Consequently, it is rather difficult to ascribe observed 
phenotypical abnormalities to a specific molecular pathway due to possible pleiotropic 
effects. The conditional gene deletion method is to a large extent circumventing this 
problem. It uses a Cre-loxP system, allowing deletion of genes in a specific cell type or 
region of the brain (Fig. 1-7) (Tsien et al., 1996a). This system involves generation of two 
mouse lines. In one line, the Cre recombinase from bacteriophage P1 is expressed under 
the control of a cell-type specific promoter, e.g. the CaMKII promoter. In the second line, 
the target DNA region (usually a gene or a fragment thereof) is floxed (i.e. flanked by loxP 
sites), using homologous recombination-based gene targeting. Breeding the two mice 
together, leads to generation of the mouse with cell-type (or regionally) restricted 
deletion of the floxed allele. Using the Cre-loxP system, Tsien et al. generated a mouse with 
the NR1 subunit of receptor deleted almost exclusively in the CA1 region of the 
hippocampus (Tsien et al., 1996a; Tsien et al., 1996b). Severe learning impairments 
observed in this mouse confirmed and expanded the earlier-established hypothesis of the 
NMDA-Rs having crucial role in LTP and memory (Bliss and Collingridge, 1993). 
 
Fig. 1-7: Conditional gene deletion in neurons. Two transgenic mice are required. Mouse 1 expresses 
Cre recombinase under a forebrain neurons-specific CaMKII (or other cell-type specific) promoter. 
Mouse 2 expresses a floxed (i.e. flanked by loxP sites) target gene (to be deleted). Breeding mouse 1 and 
mouse 2 together leads to recombination exclusively in the cells where Cre is expressed (in this case 
forebrain neurons) (after Mayford and Kandel, 1999). 
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The Cre/Lox-P system (Sauer and Henderson, 1988) is nowadays the most common 
method for generation of cell-type-restricted knock-outs of genes in mice. Many Cre 
transgenes have been developed to spatiotemporally restrict Cre expression, including 
brain-specific (Tsien et al., 1996a; Zhuo et al., 2001; Casper et al., 2007) and inducible 
systems (Hirrlinger et al., 2006; Mori et al., 2006; Slezak et al., 2007; Gosejacob et al., 
2011). Despite obvious advantages, the Cre-loxP system still does not allow to 
unambiguously correlate the observed phenotype with the particular molecular 
mechanism. Although cell-type restricted, the deletion is achieved in a manner 
controlled only by the spatiotemporal activity pattern of the used promoter. Moreover, 
ectopic promoter activity has been reported for many Cre transgenes described to date 
(Eckardt et al., 2004; Schmidt-Supprian and Rajewsky, 2007; Martens et al., 2010; 
Wicksteed et al., 2010). Several of the abovementioned pitfalls can be circumvented by 
using inducible Cre transgenes and/or Cre activated by the co-incidental activity of two 
promoters (Kellendonk et al., 1999; Hirrlinger et al., 2006; Hirrlinger et al., 2009). 
1.8.2 The Cre/LoxP system benefits from a direct linkage between 
gene deletion and reporter activation 
As already mentioned, currently used Cre transgenes are not free of limitations 
(Schmidt-Supprian and Rajewsky, 2007). One way to validate Cre-recombination 
fidelity is by employing reporter genes, which are activated by Cre recombinase. The 
reporter gene may be ubiquitously expressed and activated by Cre-mediated excision 
of the floxed STOP codon located upstream of the reporter coding region (Cre-excision 
reporter). Alternatively, a gene deletion may be directly linked to reporter activation, 
resulting in a functional replacement of the deleted gene with a reporter gene (gene 
inactivation reporter) (Requardt, Kaczmarczyk et al., 2009). Such a direct link between 
gene deletion and reporter activation has been previously described (Moon et al., 
2000). In astrocytes, such approach was used for reporting deletion status of connexin 
Cx43 (Theis et al., 2003a). A direct link between gene deletion and reporter activation 
allows for a quick and easy estimation of the recombination status, specificity, and for 
a clear identification of gene deletion in the target cells while the adjacent cells still 
express the transgene at high levels (Requardt, Kaczmarczyk et al., 2009). It also 
enables an ad-hoc, rigid verification of gene inactivation, to large extent eliminating 
the necessity of performing the post-experimental validation of recombination fidelity. 
Moreover, unlike the Cre-excision reporters, the gene inactivation reporters can be 
successfully used in multiple transgenic mice. 
1.8.3 Spatiotemporal control of gene overexpression 
Spatiotemporally-restricted overexpression of genes is alternative strategy to study 
their function in vivo. This can be achieved by using the bi-transgenic tTA/tetO system 
(Mayford and Kandel, 1999), employing tetracycline-responsive promoter elements to 
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drive the transgene expression (Gossen and Bujard, 1992). The system requires two 
transgenic mice lines: (1) expressing the tetracycline-responsive transcription factor 
(tTA) under control of cell-type specific promoter and (2) expressing the transgene 
under the tetracycline responsive promoter. Breeding the two lines together leads to 
generation of a double transgenic mouse line, expressing the transgene exclusively in 
the cells where tTA is expressed (e.g. forebrain neurons in case of CaMKII-driven tTA) 
(Fig. 1-8). Administration of doxycycline (tetracycline analogue) modulates the tTA 
activity, allowing for temporal control of transgene expression. Depending on the nature 
of tTA, the system (termed the “tet” system) has two varieties: (1) the tet-off system, 
where administration of doxycycline (dox) renders the tTA inactive, and (2) the tet-on 
system, where dox is required for tTA activation. The tet-off system has become more 
commonly used, and has been successfully applied to study the function of the CPEB1-4 
protein family in forebrain neurons (see also section 1.6).  
 
Fig. 1-8: Conditional gene overexpression in neurons. Two transgenic mice are required. In mouse 1,         
a cell-type-specific (e.g. forebrain-neurons specific CaMKII)promoter drives expression of the tTA. Mouse 2 
expresses the transgene (in this example a dominant-negative CPEB1-4) under the minimal eukaryotic 
promoter and the tet operator (tetO). Breeding mouse 1 and mouse 2 together leads to a double transgenic 
mice which exhibit transgene expression exclusively in the cells where tTA is expressed (e.g. forebrain 
neurons in case of CaMKII-driven tTA). Administration of doxycycline renders tTA inactive, allowing for 
temporal control of transgene expression (after Mayford and Kandel, 1999, modified). 
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2 Experimental Goals 
Goal of the thesis was to investigate the expression of CPEBs and their splice isoform 
in selected cell types in mouse brain, with special emphasis on microglial cells. I aimed 
at identification of novel CPEB targets present in astrocytes and microglia. I also 
embarked on establishing and optimizing appropriate methodologies (i.e. mRNA pull 
down) for assessment of mRNA binding specificity of CPEBs, in order to test the 
potential specificity overlap between CPEB family members. Focusing on the CPEB-3 
protein, I have embarked on testing its function in transgenic mice overexpressing 
CPEB3a-EGFP fusion protein in principal neurons. Based on the hypothesis formulated 
by Theis et al. (2003b), I wanted to investigate the phosphorylation of CPEB-3 in vitro 
and in vivo, identify the protein kinases involved, and the function of the process. To this 
end, I also aimed at generating and characterizing a custom-made phosphospecific 
polyclonal antibody against CPEB-3. Using embryonic stem-Cell-derived microglia 
(ESdM), I intended to test the putative translational regulation of microglial tPA by 
CPEBs. To do so, I aimed at establishing a DN-CPEB1-4 overexpression, using retroviral 
gene targeting followed by fluorescence-activated cell sorting (FACS). Finally,                      
I embarked on developing a quality control method for hGFAP-Cre mediated gene 
deletion. 
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3 Materials and Methods 
3.1 Molecular biology 
All the reagents for molecular biology work were of analytical grade, and were 
purchased from Sigma, Carl-Roth, Roche or Merck. Small volume (up to 1 ml) solutions 
and reaction mixtures were made with sterile water. Double distilled (ddH2O) or 
deionized water was used for larger volumes. 
3.1.1 Solutions 
DNA loading buffer (6x) 
Component Concentration 
Glycerol 30% (v/v) 
Xylene cyanol 0.1 % (w/v) 
Bromophenol blue 0.1 % (w/v) 
Coomassie staining solution (1x) 
Component Concentration 
EtOH 40% (v/v) 
Acetic Acid 10% (v/v) 
Coomassie Brilliant Blue 0.1% (w/v) 
TBE buffer (10x) 
Component Concentration 
Tris-Cl 1 M 
Boric acid 0.83 M 
EDTA 10 mM 
TBS-T buffer (1x) 
Component Concentration 
Tris-Cl, pH 7.4 25 mM 
NaCl 150 mM 
Tween 20 0.05 % (v/v) 
RIPA buffer (modified) (1x) 
Component Concentration 
Tris-Cl, pH 7.4 50 mM 
NaCl 150 mM 
Nonidet P40 0.5 % (v/v) 
Na-DOC 0.5 % (w/v) 
Triton X-100 1 % (v/v) 
SDS 0.5 % (w/v) 
Complete Mini Protease 
Inhibitor Cocktail* 
1 tab./50 ml 
(*) Added directly before use 
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PIL (Phosphatase Inhibitor Lysis) buffer (1x) 
Component Concentration 
Tris-Cl, pH 7.5 50 mM 
NaCl 50 mM 
NaF 50 mM 
EDTA 2 mM 
Triton X-100 1 % (v/v) 
NP-40 1 % (v/v) 
NaVO3 2 mM 
Sucrose 270 mM 
Complete Mini Protease Inhibitor Cocktail* 1 tab./10 ml 
PhosStop Phosphatase Inhibitor Cocktail * 1 tab./10 ml 
(*) Added directly before use 
Protein sample buffer (SDS-PAGE) (1x) 
Component Concentration 
Tris-Cl, pH 6.8 50 mM 
DTT 100 mM 
SDS 2 % (w/v) 
Glycerol 10 % (v/v) 
Bromophenol blue 0.01 % (w/v) 
Firefly luciferase substrate solution (1x) 
Component Concentration 
Tricine, pH 7.8 30 Mm 
MgSO4 3.75 mM 
ATP 0.75 mM 
DTT 1.25 mM 
Coenzyme-A 67 µM 
D-luciferin, Na-salt 0.5 mM 
(*) After addition of D-luciferin, 1x solution was 
stored at -80oC and protected from light 
3.1.2 Solutions for RNA work 
All solutions for RNA work were prepared from RNA work-designated reagents and 
sterilized by filtration (pore size 0.22M). 
RNA co-IP lysis buffer (1x) 
Component Concentration 
HEPES 10 mM 
NaCl 200 mM 
EDTA 30 mM 
Triton X-100 0.5% (v/v) 
Complete Mini Protease Inhibitor Cocktail* 1 tab./10ml 
RNAsin* 200 U/ml 
tRNA* 5 g/ml 
 (*) Added directly before use 
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RNA co-IP wash buffer (1x) 
Component Concentration 
HEPES 10 mM 
NaCl 500 mM 
EDTA 30 mM 
Triton X-100 0.5% (v/v) 
Complete Mini Protease Inhibitor Cocktail* 1 tab./50ml 
RNAsin* 100 U/ml 
    (*) Added directly before use 
3.2 Cell culture reagents 
Unless stated otherwise, all the solutions used for cell culture work were purchased 
from Invitrogen/Gibco, Germany. 
3.2.1 Media formulations 
Fetal Calf Serum (FSC) medium component was heat-inactivated at 56oC for 30min. 
DMEM / FCS cell culture medium (500ml) 
Component Amount/Concentration 
DMEM with 25mM Glucose 500 ml 
FCS (heat-inactivated) 10% 
Penicillin/Streptomycin (100x)* 1% 
(*) optional 
MEF cell culture medium (500ml) 
Component Amount/Concentration 
DMEM with 25mM Glucose 500 ml 
FCS (heat-inactivated) 10% 
L-Glutamine 6 mM 
MEM Non-Essential Amino Acids 0.1 mM 
MEM Sodium Pyruvate 1 mM 
Penicillin/Streptomycin (100x)* 1% 
(*) optional 
Trans-MEF cell culture medium (500ml) 
Component Amount/Concentration 
DMEM with 25mM Glucose 500 ml 
FCS (heat-inactivated) 2% 
L-Glutamine 6 mM 
MEM Non-Essential Amino Acids 0.1mM 
MEM Sodium Pyruvate 1 mM 
Chloroquine (Sigma, Germany) 50 M 
N2 cell culture medium (500ml) 
Component Amount/Concentration 
DMEM / F12 500 ml 
N2 supplement (100x) 1% 
L-Glutamine 0.48 mM 
D-Glucose (Sigma, Germany) 15.3 µg/ml 
Penicillin/Streptomycin (100x)* 1% 
                  (*) optional 
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3.2.2 Cell culture reagents 
Reagent Provider 
PBS Invitrogen 
PBS (for FACS) Lonza 
Opti-MEM Invitrogen 
Trypsin-EDTA (0.05%) Invitrogen 
Lipofectamine 2000 Invitrogen 
Polybrene Sigma 
Chloroquine Sigma 
Forskolin New England Biolabs 
3.2.3 Cell culture consumables 
All cell culture consumables/plasticware were purchased from Sarstedt, Grainer Bio-
One, and Carl Roth. ESdM cells were cultured in standard Tissue Culture (TC) 
dishes/flasks purchased from Greiner Bio-One. 
3.2.4 Antibodies 
Antigen Coupling Immunogen Type 
Host   
specie 
Application Source 
Catalogue 
number/ 
reference 
FLAG - synthetic peptide M Ms IP, WB Sigma F3165 
CPEB-1 - synthetic peptide P Rb IP, WB, ICC Eurogentec custom-made 
CPEB-2 - synthetic peptide P Rb ICC Eurogentec custom-made 
CPEB-3 - synthetic peptide P Rb IP, WB Eurogentec custom-made 
CPEB-3 - synthetic peptide P Rb WB, ICC Abcam ab10883 
CPEB-4 - synthetic peptide P Rb ICC Eurogentec custom-made 
GAPDH - 
full length              
GAPDH protein 
M Ms WB Abcam ab9484 
Mouse IgG HRP 
mouse IgG             
(heavy + light chain) 
M Gt WB Pierce 31430 
Rabbit IgG HRP 
rabbit IgG              
(heavy + light chain) 
M Gt WB Pierce 31460 
Cx43 - 
synthetic peptide        
(C-terminal) 
P Rb WB 
A gift from 
Radek 
Dobrowolski 
(Theis et al., 2001) 
Phospho-
CPEB3-
S419/S420 
- syntetic peptide P Rb WB Eurogentec custom-made 
GluR2 - 
recominant GluR2 
fusion protein 
M Ms WB Millipore MAB397 
-tubulin - 
microtubules from 
chicken embryo brain 
M Ms WB Sigma T9026 
-actin - 
synthetic peptide        
(C-terminal) 
M Ms WB Sigma A3853 
Cre 
recombinase 
- 
bacteriophage P1       
Cre protein 
P Rb WB Novagen 69050-3 
CD11b APC 
glycosylated form of 
CD11b antigen 
M Rt FACS Invitrogen CD11b05 
Tab. 3-1: List of the antibodies used. IgG – immunoglobulin; Coupling: HRP – Horseradish peroxidase 
Type: M – monoclonal, P – polyclonal; Host specie: MS – Mouse, Rb – Rabbit, Gt – Goat, Rt – Rat; 
Application: IP – immunoprecipitation, WB – Western blot (immunoblot), ICC – immunocytochemistry, 
FACS – Fluorescence Activated Cell Sorting. 
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3.3 PCR and RT-PCR oligonucleotides 
The majority of PCR oligonucleotides was designed using the Primer3 online tool 
(Rozen and Skaletsky, 2000). TaqMan primers and probes were designed with Primer 
Express 3.0 (Applied Biosystems). 
3.3.1 3’RACE oligonucleotides 
target gene RACE primer sequence 
CaMKII 5’-AACTGTCCAGAGCCCACCCTCATCTG-3’ 
Cx43 5’-AACAGGCTTGAACATCAAGCTGCCAATC-3’ 
tPA 5’-CAAAGAAAGCCCAGCTCCTTCAATCCAG-3’ 
Tab. 3-2: Gene-specific oligonucleotides used for 3’RACE amplification. 
3.3.2 Primers for cloning and site directed mutagenesis of 3’UTRs 
# Oligonucleotide sequence Target gene Application 
1 5’-GCACTCTAGACTCTCTCTCTTTCTTTTTTAATCTGTG-3’ CaMKII 
Cloning of 3’UTR  
(forward) 
2 5’-CGACGTCGACAAATTTGTAGCTATTTATTCCACTG-3’ CaMKII Cloning of 3’UTR  (reverse) 
3 5’-GCACTCTAGACTCTCTCTCTTTCGGTACCAATCTGTG-3’ CaMKII 
Cloning of 3’UTR  
(forward) / Mutating 
proximal CPE 
4 5’-GAAGAGATGTCTGGTGTACTCTTGGCGTTTTCAG-3’ CaMKII 
Mutating distal CPE by SOE 
PCR (forward) 
5 5’-CTGAAAACGCCAAGAGTACACCAGACATCTCTTC-3’ CaMKII 
Mutating distal CPE by SOE 
PCR (forward) 
7 5’-GCACTCTAGACACTCCTCAACTCTTGGGACATA-3’ tPA 
Cloning of 3’UTR  
(forward) 
8 5’-CGACGTCGACAAAGTGTGAAAAATACCTCTGAATTTA-3’ tPA Cloning of 3’UTR  (reverse) 
9 5’-GGAGAACTGTATGAGGTCACCAATTGATGAATAAC-3’ tPA 
Mutating proximal CPE by 
SOE PCR (forward) 
10 5’-GTTATTCATCAATTGGTGACCTCATACAGTTCTCC-3’ tPA 
Mutating proximal CPE by 
SOE PCR (reverse) 
11 5’-CACTAGTATATTTATAGGTCACCCTATTTTAGTTTTTAC-3’ tPA 
Mutating distal CPE by SOE 
PCR (forward) 
12 5’-GTAAAAACTAAAATAGGGTGACCTATAAATATACTAGTG-3’ tPA 
Mutating distal CPE by SOE 
PCR (reverse) 
13 5’-GCACTCTAGAATTGAAATGTCGAGTTATCATGTTT-3’ Cx43 
Cloning of 3’UTR  
(forward) 
14 5’-CGACGTCGACATTATACTAAATTAAAATTTTATTGAATAAAGAAC-3’ Cx43 Cloning of 3’UTR  (reverse) 
15 5’-GTCGACATTATACTAGGTTGTCCTTTTATTGAATAAAGAAC-3’ Cx43 
Cloning of 3’UTR  
(forward) / Mutating distal 
CPE 
16 5’- AATCTAGAGAAACCCTGGACCACCCAC-3’ GAPDH 
Cloning of 3’UTR  
(forward) 
17 5’- AAGTCGACGGGTGCAGCGAACTTTATTGAT-3’ GAPDH Cloning of 3’UTR  (reverse) 
Tab. 3-3: PCR oligonucleotides used to generate wild-type and mutated 3’UTR luciferase reporter 
constructs. Introduced restriction sites (SalI: TCTAGA or XbaI: GTCGAC) were underlined. Nucleotides 
mutated with respect to wild-type genes were shown in bold. 
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3.3.3 Taq-Man sqRT-PCR oligonucleotides 
Unless specified otherwise, Taq-Man oligonucleotides were designed using Primer 
Expert 3.0 software (Applied Biosystems) and synthetized by Eurogentec. In case of 
mouse -actin, a commercial internal control assay with 6-carboxyfluorescein 
amidite/Minor Groove Binder (6-FAM/MGB) probe (Applied Biosystems) was used. 
#  Oligonucleotide sequence Target gene Species 
1 
Forward 5’-GGCTCCCGCTGAATTGG-3’ 
Luciferase Firefly Reverse 5’-GCGACACCTGCGTCGAA-3’ 
Probe 5’-ATCCATCTTGCTCCAACACCCCAACA-3’ 
2 
Forward 5’-ACACCTCCCAAGTCCTTTATGAAT-3’ 
-catenin MouseReverse 5’-CCCGTCAATATCAGCTACTTGCT-3’ 
Probe 5’-AGGCTTTTCCCAGTCCTTCACGCAA-3’ 
3 
Forward 5’-GCTATGAAGGATGGGCAACT-3’ 
Porphobilinogen 
deaminase (PBGD) 
Human Reverse 5’-GTGATGCCTACCAACTGTGG-3’ 
Probe 5’-TGCCCAGCATGAAGATGGCC-3’ 
4 
Forward 5’-CGACAGTCAGCCGCATCTT-3’ Glyceraldehyde-3-
phosphate 
dehydrogenase (GAPDH) 
Human Reverse 5’-CCGTTGACTCCGACCTTCAC-3’ 
Probe 5’-CGTCGCCAGCCGAGCCACA-3’ 
5 
Forward 5’-GAGACGGCCGCATCTTCTTGT-3’ Glyceraldehyde-3-
phosphate 
dehydrogenase (GAPDH) 
Mouse Reverse 5’-CACACCGACCTTCACCATTTT-3’ 
Probe 5’-CAGTGCCAGCCTCGTCCCGTAGA-3’ 
6 
Forward 5’-ATTCAGCATAGAGAGAGAGGCTAGA-3’ 
CPEB1 Mouse Reverse 5’-CCAGGTACACGTAGCTTCATTCAC-3’ 
Probe 5’-TCCACCGGCAGGCTGCAGC-3’ 
7 
Forward 5’-TGCAGCAGAGGAACTCGTACA-3’ 
CPEB2 Mouse Reverse 5’-CCAACCGCTGTTCTGATGGT-3’ 
Probe 5’-CCACCACCAGCCTCTTCTGAAACAGTCT-3’ 
8 
Forward 5’-GCGCTCAGGTGGGACAGA-3’ 
CPEB3 Mouse Reverse 5’-GGGTTTTGCTTTTGTCCATCA-3’ 
Probe 5’-CAGCTGCGCAAACCATGCAGGA-3’ 
9 
Forward 5’-TTGAACAGGGCTGACAACATTT-3’ 
CPEB4 Mouse Reverse 5’-CCAGTGAGTGCATGTCAAACG-3’ 
Probe 5’-CCTTTTCCGGAACGCCCCAGG-3’ 
Tab. 3-4: Taq-Man sqRT-PCR oligonucleotides. Except for the Porphobilinogen deaminase (PBGD), 
probes were labeled with carboxytetramethylrhodamine (TAMRA) (3’-end) and 6-FAM (5’-end). PBGD 
probe was labeled with TAMRA (3’-end) and Black Hole Quencher-1 (BHQ-1) (5’-end). 
3.3.4 SYBR Green sqRT-PCR oligonucleotides 
#  Oligonucleotide sequence Target gene Species 
1 
Forward 5’-TGTTGTTTTGGAGCACGGAA-3’ 
Luciferase Firefly 
Reverse 5’-ACTCCTCCGCGCAACTTTT-3’ 
2 
Forward 5’-TGTGCCCATCTACGAGGGGTATGC-3’ 
-actin Mouse
Reverse 5’-GGTACATGGTGGTGCCGCCAGACA -3’ 
Tab. 3-5: SYBR Green sqRT-PCR oligonucleotides. 
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3.3.5 Oligonucleotides for generating lentiviral vectors 
# Oligonucleotide sequence Target sequence Application 
1 5’- GACTGCAGCCGGATCCACCATGGACTACAAAGACCATGAC-3’ FLAG Cloning of mCPEB-1/-
3/-DN (forward) 
2 5’- CGGTACCCGGGGATCCCGGTTCTTCTGGTTCCTCATTAG-3’ CPEB1 ORF Cloning of mCPEB-1/-
DN (reverse) 
3 5’- CGGTACCCGGGGATCCCGGCTCCAGCGGAACGGGAC-3’ CPEB3 ORF 
Cloning of mCPEB-3 
(reverse) 
4 5’- GATCCAGTTTGGTTAATTAATACCGGGTAGGGGAGGCGCTTTTC-3’ PGK promoter 
Cloning of PGK 
promoter (forward) 
5 5’- CGGTACCCGGGGATCCGGCTGCAGTCGAAAGGCCCGGA-3’ PGK promoter 
Cloning of PGK 
promoter (reverse) 
Tab. 3-6: PCR oligonucleotides used to generate lentiviral expression constructs. Restriction sites 
(PacI: TTAATTAA or BamHI: GGATCC) were underlined. In-Fusion overhangs, homologous to the target 
vector sequence, were highlighted. 
3.3.6 Primers for sequencing of 3’UTR luciferase constructs 
# Oligonucleotide sequence Target region 
1 3’-AACTCGACGCAAGAAAAATCAGAGAG-5’ 
Upstream of XbaI restriction site 
(forward read) 
2 3’-CACCTGTCCTACGAGTTGCATGATAAAG-5’ 
Downstream of SalI restriction site 
(reverse read) 
Tab. 3-7: Primers used for sequencing of 3’UTR luciferase constructs. 
3.3.7 Primers for sequencing of lentiviral vectors 
# Oligonucleotide sequence Target region / purpose 
1 5’-CGGGTTTATTACAGGGACAGC-3’ 
Binds upstream of PacI restriction site / 
promoter sequencing (forward) 
2 5’-CACCTGTCCTACGAGTTGCATGATAAAG-3’ 
Binds in the PGK promoter / insert ORF 
sequencing (forward) 
3 5’-CACCACCCCGGTGAACAG-3’ 
Binds in the GFP cds promoter /  insert ORF 
sequencing (reverse) 
Tab. 3-8: Primers used for sequencing of lentiviral constructs. 
3.3.8 Primers for CPEB splice isoform analysis 
  Oligonucleotide sequence 
mCPEB-1 
Forward 5’-GGATTGGTTAACACCTTCCGTGTTTTTGGC-3’ 
Reverse 5’-AGGCCATCTGGGCTCAGCGGG-3’ 
mCPEB-2 
Forward 5’-ATGTGTTCAGGACAGACAATAGTAACA-3’ 
Reverse 5’-CAAGCTATCATCTATTGGAAATAGGGAAGA-3’ 
mCPEB-3 
Forward 5’-GGATATGATAAGGACTGACCATGAGCCTCTGAAAG-3’ 
Reverse 5’-CCATGGCTGTCATCCAAGAAGGCGTC-3’ 
mCPEB-4 
Forward 5’-CAGACCACTATGAAGAGGTTGATCCCCACG-3’ 
Reverse 5’-CCCAGGACGTTTGACATGCACTCACTG-3’ 
Tab. 3-9: Oligonucleotides used for CPEB splice isoform analysis, flanking alternatively 
spliced regions (Theis et al., 2003b). 
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3.4 Mouse lines 
All mice were bred and maintained under specific pathogen-free (SPF) conditions, by 
the House for Experimental Therapy, University of Bonn. 
Genotype Reference Source 
CX3CR1kiGFP (Jung et al., 2000) 
Kind gift from Prof. Harald Neumann, 
Institute of Reconstructive Neurobiology, 
University of Bonn 
hGFAP-Cre (Zhuo et al., 2001) 
Provided by Dr. Martin Theis, Institute of 
Cellular Neurosciences, University of 
Bonn 
CaMKII-tTA (Mayford et al., 1996) 
Provided by Dr. Martin Theis, Institute of 
Cellular Neurosciences, University of 
Bonn 
tetO-CPEB3-EGFP (unpublished) 
Provided by Dr. Martin Theis, Institute of 
Cellular Neurosciences, University of 
Bonn 
Cx30-/-;Cx43fl/fl (Wallraff et al., 2006) 
Provided by Dr. Martin Theis, Institute of 
Cellular Neurosciences, University of 
Bonn 
Tab. 3-10: Transgenic mouse lines used. 
3.5 Bacterial strains 
Item Genotype Source 
Top10 chemically 
competent E.coli 
F- mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 
ΔlacΧ74 recA1 araD139 Δ(ara-leu) 7697 galU 
galK rpsL (StrR) endA1 nupG λ- 
Invitrogen 
Stbl3 chemically 
competent E.coli 
F– mcrB mrr hsdS20(rB–, mB–) recA13 supE44 
ara-14 galK2 lacY1 proA2 rpsL20(StrR) xyl-5 λ– 
leu mtl-1 
Invitrogen 
Tab. 3-11: Bacteria strains used. 
3.6 Kits and reagents 
Item Application Provider 
mMESSAGE mMACHINE T7 Ultra 
In vitro transcription to yield translation-
competent mRNA 
Ambion 
In-Fusion 2.0 Dry-Down PCR Cloning Kit 
In-Fusion recombination-mediated 
cloning of PCR inserts Clontech 
Marathon-Ready Mouse Brain cDNA 3’RACE experiments 
Fast Link Ligation Kit Ligating restriction fragments Epicentre 
Streptavidin-HRP Chemiluminescent detection of biotin GE Healthcare 
AccuPrime Taq DNA Polymerase System CPEB splice isoform analysis 
Invitrogen 
LIVE/DEAD Fixable Dead Cell Stain Kit Dead cells discrimination in FACS 
PureLink HiPure Plasmid Midiprep Kit DNA purification from bacterial cultures  
SuperScript III Reverse Transcriptase 
Reverse transcription                                             
(RT-PCR and sqRT-PCR) 
TOPO XL PCR Cloning Kit T/A cloning 
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Item Application Provider 
PKLight Assay Kit Quantitation of in vitro phosphorylation Lonza 
T4 DNA Ligase Ligation of restriction fragments New England 
Biolabs Quick Ligation Kit Ligation of restriction fragments 
peqGOLD Gel Extraction Kit 
Purification of DNA fragments from 
agarose gels 
PeqLab 
SuperSignal West Dura Substrate 
Detection of HRP activity on 
immunoblots 
Pierce 
RNAsin Prevention of RNA degradation 
Promega ADP-Glo Assay Kit Quantitation of in vitro phosphorylation 
Wizard Plus SV Miniprep Kit DNA purification from bacterial cultures  
Omniscripts Reverse Transcriptase 
Reverse transcription                                    
(RT-PCR and sqRT-PCR) 
Qiagen 
PCR Clean-up Kit 
DNA purification after enzymatic 
reactions 
Plasmid Maxi Kit DNA purification from bacterial cultures  
RNeasy Mini-Kit RNA purification 
RNase-Free DNase Set 
Genomic DNA removal during RNA 
purification 
Expand High Fidelity PCR System Amplification of restriction inserts, RACE 
Roche 
GC–Rich Polymerase Kit CPEB3a OFR amplification 
Tab. 3-12: Commercial kits and reagents used. 
3.7 Selected equipment 
Item Model Provider 
Bioanalyzer 2100 Agilent 
FACS Cell Sorter Customized FACS DiVa Becton Dickinson 
Flow Cytometer FACS Canto II Becton Dickinson 
Microplate luminometer Centro LB 960 Berdhold Technologies 
Spectrophotometer (Nanodrop) Pearl Implen 
Quantitative PCR System 7900HT   Applied Biosystems 
Immunoblot documentation system Gene Gnome HR Syngene 
Tab. 3-13: Laboratory equipment used. 
3.8 Software 
Item Company / Reference 
MS Excel 2010 Microsoft 
SDS 5.0 sqRT-PCR software Applied Biosystems 
MultiAlign (web-tool) (Corpet, 1988) 
GeneSnap Syngene 
Lasergene Sequence Builder 7.0 Dynastar, Inc. 
FlowJo 7.6 Tri Star, Inc. 
Jalview 2.5.1 (Waterhouse et al., 2009) 
Graph Pad Prism 5.0 Graph Pad, Inc. 
Primer3 (web-tool) (Rozen and Skaletsky, 2000) 
Bioedit 7.0.9 (Hall, 1999) 
Tab. 3-14: Software used (including web-tools). 
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3.9 Molecular cloning 
Unless specified otherwise, all basic molecular biology techniques were performed 
following product manufacturer’s recommendations and/or according to the “Molecular 
Cloning” laboratory manual (Sambrook and Russell, 2001). All restriction enzymes were 
purchased from New England Biolabs. PCR reactions to amplify restriction inserts were 
done with the High Fidelity PCR system (Roche, Mannheim, Germany), unless stated 
otherwise. All the primer sequences can be found in section 3.3. The In-Fusion 
homologous recombination-mediated cloning technique (Clontech, Heidelberg, 
Germany) was also used as a cloning method for single-restriction enzyme cloning of 
long (>2kb) inserts. It was also used when an insert contained a target restriction site(s) 
of the cloning, and no suitable alternative sites on the vector existed. Vectors and cloning 
strategies were designed using Lasergene software (Dynastar, Inc.). 
3.9.1 Rapid amplification of 3’ cDNA ends (3’RACE) 
To determine the 3’UTR termini of CPEB target mRNAs, the 3’RACE method was used. 
Gene specific primers used for 3’RACE experiments are listed in Tab. 3-2. Whole mouse 
brain “Marathon-Ready” cDNA (Clontech) served as a template. An anchor 
oligonucleotide (AP1) provided with the cDNA was used as a reverse primer. Reaction 
components and PCR temperature cycle conditions are listed in Tab. 3-15 and 3-16, 
respectively. 3’RACE PCR products were visualized on EtBr-stained agarose gels, 
purified, and inserted into the TA cloning vector XL-TOPO. Obtained clones were 
sequenced with vector-specific M13 forward and M13 reverse primers. 
Reagent Amount 
Stock 
concentration 
cDNA template 5l ~0.1ng/l 
Polymerase Mix 0.5l 3.5U/l 
dNTP mix 1l 10mM 
Gene-specific primer (GSP) 1l 10M 
Anchor Primer (AP1) 1l 10M 
Buffer with Mg2+ 10l 5x 
ddH2O 31.5l n/a 
Total volume 50l  
Tab. 3-15: 3’RACE of CPEB target cDNA – reaction 
mixture. 
Temp. Time No. of cycles 
94oC 1 min  
94oC 15 s 
     x 5 
72oC 3 min 
94oC 15 s 
     x 5 
70oC 3 min 
94oC 15 s 
     x 25 
68oC 3 min 
68oC 10 min  
4oC hold  
Tab. 3-16: 3’RACE of CPEB target    
cDNA – temperature profile
3.9.2 Generation of luciferase reporter constructs 
The pGL4.75[hRluc/CMV] Renilla luciferase-encoding plasmid (GenBank accession 
no. HC872744) was used as backbone for the generation of all CPE-containing reporter 
constructs, further used for RNA co-IP experiments and luciferase reporter assays.  
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3.9.2.1 Cloning of Firefly luciferase Open Reading Frame (ORF) 
The firefly luciferase ORF was extracted from the pGL3-Control vector (GenBank 
accession no. U47296.2) using XbaI and HindIII restriction enzymes.  The excised 
fragment was ligated to respective sites in pGL4.75[hRluc/CMV], replacing the Renilla 
luciferase ORF. The obtained vector was termed pGL4.75[luc+/CMV]. 
3.9.2.2 Cloning of T7 promoter 
A T7 promoter-containing dsDNA insert was ligated into HindIII restriction site of the 
pGL4.75[luc+/CMV] and pGL4.75[hRluc/CMV] plasmids. This generated 
pGL4.75[luc+/T7/CMV] and pGL4.75[hRluc/T7/CMV] constructs, respectively. To this end, 
complementary oligonucleotides containing the T7 promoter flanked with compatible 
cohesive overhangs were used (see Tab. 3-17). The oligonucleotides contained 3’ and 5’ 
phosphate groups to facilitate ligation. An EcoRI restriction site was included for 
identification of positive clones and elimination of multiple insertions (via EcoRI digestion 
and re-ligation). The oligonucleotides were reconstituted in water and 25 mM stock 
solution in 10 mM Tris pH 7.4 was prepared. The mixture was boiled for 5 min at 95oC to 
ensure proper annealing. For ligation, a vector-to-insert ratio of 1:10 was used. 
strand sequence 
sense 5’-Pi-AGCTTGAATTCTAATACGACTCACTATAGGGAGAA-Pi-3’ 
antisense     3’-Pi-ACTTAAGATTATGCTGAGTGATATCCCTCTTTCGA-Pi-5’ 
Tab. 3-17: Complementary oligonucleotides carrying the T7 promoter, with HindIII 
restriction site-compatible cohesive overhangs (underlined) and EcoRI restriction site (blue); 
Pi – phosphate groups. 
3.9.2.3 Cloning of 3’UTR fragments 
The pGL4.75[luc+/T7/CMV] plasmid was cut with XbaI and SalI restriction enzymes. 
Terminal fragments of 3’UTRs (determined by 3’RACE products) were PCR-amplified to 
generate compatible restriction overhangs (for reaction setup and temperature profile, 
refer to Tab. 3-18 and 3-19, respectively.  
Reagent Amount 
Stock 
concentration 
Plasmid template 1 l 50-100ng/l 
Roche HF Polymerase Mix  0.5 l 3.5U/l 
dNTP mix 1 l 10mM 
Primer mix (For + Rev) 1 l 10M each 
Buffer with Mg2+  10 l 5x 
ddH2O 35.5 l n/a 
Total volume 50 l  
Tab. 3-18: PCR amplification of 3’UTR fragments 
– reaction mixture (done with Roche High 
Fidelity (HF) PCR system). 
 
Temp. Time 
No. of 
cycles 
94oC 2 min  
94oC 
53oC 
70oC 
15 s 
30 s 
1m:30s 
 x 30 
70oC 10 min  
4oC hold  
Tab. 3-19: PCR amplification of 
3’UTR fragments – temperature 
profile.
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PCR products were digested with XbaI and SalI restriction enzymes and cloned into 
respective sites of pGL4.75[luc+/T7/CMV], replacing the SV40 Poly(A) signal. A control 
vector containing GAPDH 3’UTR was generated in the same way. 
3.9.3 Site-directed PCR mutagenesis 
Splicing by overlap extension (SOE) PCR was used to mutate CPE elements in cloned 
3’UTR fragments. SOE PCR was performed with the Advantage HF High Fidelity PCR Kit 
(Clontech, Heidelberg, Germany). Reaction setup and temperature conditions for both 
rounds of SOE PCR are summarized in Tab. 3-20 and 3-21, respectively. 
Reagent Amount 
Stock 
concentration 
Plasmid DNA template   
(1st round) / 1st round SOE 
PCR products (2nd round) 
1 l / 
1 µl each 
50-100 ng/l 
Polymerase Mix  0.5 l 3.5 U/l 
dNTP mix 1 l 10 mM 
Primer mix (For + Rev) 1 l 10 M each 
Buffer with Mg2+  10 l 5x 
ddH2O up to 50l n/a 
Total volume 50 l  
Tab. 3-20: 1st and 2nd round of SOE PCR reaction mixes.
 
Temp. Time 
No. of 
cycles 
94oC 1 min  
94oC 15 s 
  x 35 56oC 30 s 
68oC 90 s 
68oC 10 min  
4oC hold  
Tab. 3-21: 1st and 2nd round of SOE 
PCR - temperature profile. 
3.9.4 Generation of a FLAG-EGFP control vector 
The EGFP ORF was excised from pEGFP-N1 plasmid (Clontech) using HindIII and XbaI 
restriction enzymes, and then ligated in respective sites of the p3xFLAG-CMV-7.1 vector. 
3.9.5 Generation of lentiviral protein expression vectors 
A modified pFTM3GW (GenBank accession no. FJ797421) 3rd generation lentiviral 
transfer vector (Geller et al., 2007), kindly provided by Dr. Elena Baron (AG Schoch, 
Institute of Neuropathology, University of Bonn), served as backbone for generation of 
lentiviral expression vectors. The vector lacked a synthetic transcription blocker TB 
(present in the original pFTM3GW plasmid) and contained an EGFP reporter. As a first 
step, the mouse PGK promoter (template kindly provided by Dr. Yiner Wang, AG 
Neumann) was cloned between PacI and BamHI restriction sites of the vector. Then, 
FLAG-tagged CPEB-1, DN-CPEB1-4 and CPEB-3 cDNA was cloned into the BamHI site of 
the vector, in frame EGFP ORF. As templates for amplification of the FLAG-tagged CPEBs, 
p3xFLAG-CMV-7.1 vectors (Sigma Aldrich, Munich, Germany) containing the respective 
CPEB ORFs were used. In case of hight GC content in the CPEB-3 DNA sequence, a GC-
Rich PCR System (Roche, Mannheim, Germany) was used. The respective reaction setups 
and temperature profiles were summarized in Tab. 3-22 and 3-23 (CPEB-1 and DN-
CPEB) and Tab. 3-24 and 3-25 (CPEB-3).  Obtained positive clones were identified by 
colony PCR. The recombinase-deficient Stbl3 E.coli strain was used to propagate the 
Doctoral Thesis – Lech Kaczmarczyk Materials and Methods 
-33- 
plasmids. To ensure that no undesirable recombination between Long Terminal Repeats 
(LTR) of the vector occurred during consecutive cloning steps, HindIII restriction 
endonuclease digestion was routinely performed to confirm the expected band pattern. 
Reagent Amount 
Stock 
concentration 
Plasmid template 1 l 50-100 ng/l 
Roche HF Polymerase Mix  0.5 l 3.5 U/l 
dNTP mix 1 l 10 mM 
Primer mix (For + Rev) 1 l 10 M each 
Buffer with Mg2+  10 l 5x 
ddH2O 35.5 l n/a 
Total volume 50 l  
Tab. 3-22: PCR amplification of CPEB-1 and DN-CPEB1-4 
ORF fragment - reaction mixture. 
Temp. Time 
No. of 
cycles 
94oC 2 min  
94oC 
60oC 
70oC 
15 s 
30 s 
3m+3s incr./cycle 
x 35 
70oC 10 min  
4oC hold  
Tab. 3-23:  PCR amplification of 
CPEB-1 and DN-CPEB1-4 ORF 
fragment - temperature profile. 
 
Reagent Amount 
Stock 
concentration 
Reaction 
Mix 1 
Plasmid template 1 l 50-100 ng/l 
Primer mix (For + Rev) 1 l 10 M each 
dNTP mix 1 l 10 mM 
GC Rich resolving solution 15 l n/a 
ddH2O 17 l n/a 
 Total volume 35 l  
Reaction 
Mix 2 
Enzyme mix 1 l 3.5 U/l 
GC Rich Polymerase Buffer 10 l 5x 
ddH2O 4 l n/a 
 Total volume 15 µl  
                          Final reaction volume 50 µl  
Tab. 3-24: PCR amplification of CPEB-3 ORF fragment reaction 
mixtures (done with Roche  GC-Rich Polymerase system). 
Temp. Time 
No. of 
cycles 
94oC 3 min  
94oC 30 s 
30 s 
2m:30s+5s 
incr./cycle 
x 35 
55oC 
70oC 
70oC 10 min  
4oC hold  
Tab. 3-25: PCR amplification of 
CPEB-3 - temperature profile.
3.9.6 DNA sequencing 
Sequencing of plasmid DNA and PCR products was done by Qiagen (Qiagen Genomic 
Services, Hilden, Germany). Obtained sequencing reads were of Phred20 quality. The 
company also provided standard sequencing primers. The critical sequencing reactions 
were confirmed by performing the opposite sequencing read of the same sequence. 
Additionally, in case of ambiguous bases/mismatches, the sequencing chromatograms 
were manually inspected for errors, using Bio-Edit software (Hall, 1999). 
3.10 Generation of custom polyclonal antibodies 
Custom polyclonal antibodies directed to CPEBs 1-4 were generated by Eurogentec 
GmbH (Cologne, Germany). The service included peptide synthesis, rabbit immunization 
and affinity purification of the obtained antibodies from the crude serum.  Peptides (16-
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18 amino acids long) were chosen on the basis of hydrophobicity (Kyte and Doolittle, 
1982), antigenic index (Jameson and Wolf, 1988) and surface probability (Emini et al., 
1985). The following peptides were chosen (cysteine residues added to the sequences 
for coupling purpose were underlined): RGIHDQLPDFQDSEETVT and 
CTWSGQLPPRNYKNPI (CPEB-1), CLQQRNSYNHHQPLLK and LQLPAWGSDSLQDSWC 
(CPEB2), LSFHQPPQQPPPPQEPTA and QPPQPAQPPQAQPSQQ (CPEB-3), and 
SENSNGKEKLRIESPC and KPPSPWSSYQSPSPTP (CPEB-4). Keyhole limpet hemocyanin 
(KLH) was used as a carrier protein. Peptide coupling was done via cysteine –(SH) 
groups or (where applicable) –(NH2) groups, using m-Maleimidobenzoyl-N-
hydroxysuccinimide (MBS) or glutaraldehyde methods, respectively. For each CPEB, two 
specific pathogen-free (SPF) rabbits were injected 4 times, with 200g of each of both 
peptides, in 2-week intervals. 87 days after the first immunization, the animals were 
sacrificed and bled, and affinity purification was performed. 
3.11 Generation of CPEB-3a phosphospecific 
antibodies 
Custom polyclonal antibodies directed to the phosphorylated form of CPEB3a was 
generated by Eurogentec GmbH (Germany). The antibody was directed to a region 
surrounding the serine residues S419 and S420. The service included peptide synthesis, 
rabbit immunization and cross-affinity purification of the obtained antibodies from the 
crude serum.  The RRGRSSLFPFEDC peptide was chosen for immunization (cysteine residue 
added to the sequences for coupling purpose was underlined). Bi-phosphorylated, two 
mono-phosphorylated (with either S419 or S420 phosphorylated) and non-phosphorylated 
versions of the peptide were synthetized. KLH was used as a carrier protein. Two SPF 
rabbits were immunized with the mixture of 3 peptides: the bi-phosphorylated and the two 
mono-phosphorylated. The better responsive animal (as determined by indirect ELISA) was 
chosen for further production steps. The affinity purification was performed on Toyopearl 
AF-Amino-650 matrix, sequentially on 2 columns. On the first column, containing 
immobilized bi-phosphorylated peptide, antibodies recognizing phosphorylated and non-
phosphorylated peptides were captured. On the second column, containing immobilized 
non-phosphorylated peptide, the first column eluate was depleted of the antibodies non-
specific to phosphorylation (the final product was the second column flow-through).  
Elution was performed with 100 mM Glycine, pH 2.5. The performance of the obtained 
antibody fractions was assessed by indirect ELISA.  
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3.12 Western blotting 
Tissue and cell culture lysates were prepared in a modified RIPA lysis buffer 
supplemented with protease inhibitor cocktail (Roche, Mannheim, Germany). Tissue 
was homogenized with a pestle in a 1.5-ml tube. Cultured cells were scraped with a cell 
scraper in ice-cold RIPA modified lysis buffer. Samples were subsequently disrupted 
with a 27-gauge needle, and incubated on ice for 10 min. Supernatants were collected 
after 20-min centrifugation at 13.000 g at 4oC. Total protein content was assayed with a 
BCA kit (Pierce) and 10-100 g of total protein per loading was used. Lysates were 
mixed with denaturing sample buffer and heated for 6 min at 95oC. Proteins were 
separated by discontinuous SDS-PAGE (Laemmli, 1970) in denaturing conditions and 
electroblotted onto a PVDF membrane. Membranes were blocked with 5% milk powder 
in TBS-T buffer, pH 7.4, and incubated O/N at 4oC with primary antibodies on an orbital 
shaker. For membrane reprobing, “Restore” stripping buffer (Pierce) was used. 
Membranes were usually re-blocked after stripping for 0.5–2 h. For detecting HRP 
activity, “West Dura” substrate (Pierce) was used and generated chemiluminescence 
was detected with the Gene Gnome digital documentation system (Synoptics, 
Cambridge, UK). Raw data analysis and densitometry were performed with GeneTools 
quantification software (Synoptics). Normalized values obtained were tested for 
significant differences with  nonparametric Mann-Whitney test and where applicable 
with Student’s t-test. 
3.13 Immunocytochemical staining of the BV-2 cells 
BV-2 cells were seeded on glass coverslips and grown for 48 hours (or until 
confluence). Cell culture medium was removed, coverslips were washed with PBS and 
fixed for 10 min with 4% PFA (in PBS) at room temperature. After fixation, cell 
membranes were permeabilized by incubation in 0.5% Triton X-100, followed by 1 h 
blocking with 5% normal goat serum (NGS) at room temperature. Cells were stained 
with affinity purified primary polyclonal antibodies directed to CPEBs 1-4, at the 
following dilutions: CPEB1 (custom-made) – 1:100, CPEB2 (custom-made) – 1:250, 
CPEB3 (Abcam) – 1:100, CPEB4 (custom-made) – 1:100. Antibodies were diluted in PBS 
supplemented with 2.5% NGS. Cells were incubated with primary antibody for 2 h at 
room temperature (or overnight at 4oC), followed by 1 h incubation with Alexa594-
coupled goat-anti-rabbit secondary antibody at 1:500 dilution (in PBS). Counterstaining 
was performed with Hoechst dye for 5 min. Coverslips were mounted using the 
PermaFluor mounting medium (Thermo Scientific). 
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3.14 Cell culture maintenance and transfection 
Transfection was performed with Lipofectamine 2000 (Invitrogen), according to the 
manufacturer’s protocol. Cells were usually transfected at 80-95% confluence. Amounts 
of DNA and lipofectamine used were individually optimized for each experiment. 
3.14.1 HeLa cell culture 
HeLa cells (kindly provided by Dr. Bernd Evert, Department of Neurology, University 
of Bonn) were cultured as a monolayer in DMEM supplemented with 10% FCS. Cells 
were grown at 37°C in a 5% CO2 atmosphere. When confluent, cells were split by 
trypsinization. For cryopreservation, 2-4 x 106 cells were suspended in 1 ml FCS 
supplemented with 10% DMSO, frozen in a freezing box, and stored in liquid N2. 
3.14.2 HEK-293FT culture 
HEK-293FT cells were cultured in MEF cell culture medium (see section 3.2.1) and 
grown at 37°C in a 5% CO2 atmosphere. When confluent, cells were split by 
trypsinization at 1:5 - 1:20 ratio. For cryopreservation cells were suspended in            
HEK-293FT medium supplemented with 40% FCS and 10% DMSO, frozen in a freezing 
box, and stored in liquid N2. 
3.14.3 BV-cells culture 
The murine BV2 cell line (Blasi et al., 1990) (kindly provided by Prof. Dr. Jochen 
Walter, Molecular Cell Biology Department of Neurology, University Hospital Bonn) was 
cultured in DMEM supplemented with 10% FCS. Cells were grown at 37°C in 5% CO2 
atmosphere and split by trypsinization when confluent. Cryopreservation was done as 
for HeLa cells (section 3.14.1). 
3.14.4 ESdM cell culture 
Liquid N2-stored stocks (kindly provided by Prof. Dr. Harald Neumann, Institute of 
Reconstructive Neurobiology, University of Bonn, LIFE & BRAIN Center) were rapidly 
thawed at 37°C and cultured in standard N2 medium on standard TC-dishes or TC-flasks. 
Medium was replaced every 2-3 days. When confluent (80%), cells were split at                 
a 1:3-1:8 ratio by scraping in PBS. Cells were grown at 37°C in a 5% CO2 atmosphere. For 
cryopreservation, 4 x 106 of cells were suspended in 1ml of N2-medium supplemented 
with 10% DMSO and 40% FCS, frozen in a freezing box, and stored in liquid N2. 
3.15 RNA co-immunoprecipitation (RNA co-IP) 
The procedure for the RNA co-IP experiments was initially adapted from Jones et al. 
(2008) and then modified. In case of anti-FLAG antibody co-IPs, the procedure involved 
a FLAG-EGFP fusion as a control bait protein. 
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3.15.1 Co-IP of endogenous -catenin mRNA 
3.15.1.1 Co-IP by overexpressed mCPEB-1 and mCPEB-3 proteins 
FLAG-tag expression vectors containing ORFs of bait proteins mCPEB-1 and mCPEB-3 
(p3xFLAG-CMV-7.1 backbone, cloned by Dr. Martin Theis) were chemically transfected 
into HeLa cells, typically seeded on 10 cm TC-dishes. 8 g of total DNA and 20 l of 
Lipofectamine 2000 was used per dish. Cells were harvested 24 h post-transfection by 
scraping in ice cold RNA co-IP lysis buffer, and finally disrupted with a 27G needle. Cell 
debris was pelleted by centrifugation at 15.000g at 4oC for 15 min. Subsequent 
incubation steps were performed at 4oC on a rotator (10-15 rpm). Lysates were 
precleared via 1 h incubation with 30 µl of protein A Sepharose (PAS) slurry 
(Invitrogen). Precleared lysates were incubated overnight with custom-made anti-CPEB-
1 or anti-CPEB-3 rabbit sera (1:20, Eurogentec, Cologne, Germany). To capture 
immunoprecipitated complexes, the lysates were incubated with 40 µl of PAS slurry for 
2 h. In each case, a 30 l sample was taken before the IP step, to determine input RNA 
levels. The beads were washed 8 times with ice cold RNA wash buffer and retained RNA 
was extracted using the RNeasy Mini kit (Qiagen, Hilden, Germany). The on-column 
genomic DNA digestion step was included. To detect co-immunoprecipitated mRNA, 
conventional RT-PCR for -catenin and GAPDH was performed. mRNA enrichment in 
analyzed samples was further validated with SYBR Green chemistry-based sqRT-PCR. 
3.15.1.2 Co-IP by overexpressed mCPEB-2 and corresponding Zn2+ finger deletion 
mutant 
The experiments were done as described in the section 3.15.1.1 with the following 
modifications: 1) The M2 anti-FLAG mouse monoclonal antibody (1:100, Sigma, 
Germany) was used for antigen binding in case of FLAG-tagged fusions; 2) Protein G 
Dynabeads (Invitrogen, Germany) were used to capture antigen-antibody complexes in 
case of co-IPs done with M2 anti-flag antibody; 3) Taq-Man chemistry-based sqRT-PCR 
was employed to quantitate mR levels in the input and output material.  
3.15.2 Co-IP of 3’UTR luciferase constructs 
Bait proteins (FLAG-tagged CPEB) and prey RNA constructs (luciferase gene 
appended with CPE-containing 3’UTRs - see section 3.9.2) were co-transfected and co-
expressed in HeLa cells. As a control prey, a GAPDH 3’UTR construct was used. Typically, 
per 10 cm TC-dish, 6 g of bait and 2 g of prey constructs were used with 20 l of 
lipofectamine. Cells were harvested 24 h post-transfection by scraping in ice cold RNA 
co-IP lysis buffer, and finally disrupted with a 27G needle. Cell debris was pelleted by 
centrifugation at 15.000 g at 4oC for 15 min. Subsequent incubation steps were 
performed at 4oC on a rotator (10-15 rpm). Lysates were precleared by 1 h incubation 
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with 30 µl of Protein G Dynabeads (Invitrogen). In the same time, an appropriate aliquot 
of the beads was blocked for 1 h with the RNA co-IP lysis buffer supplemented with 3% 
bovine serum albumin (BSA) and 15 µg of tRNA per 30 µl of the beads. Precleared 
lysates were incubated overnight with M2 anti-FLAG mouse monoclonal antibody 
(1:100, Sigma) and 40 µl of blocked protein G Dynabeads, in the presence of RNAsin 
(Promega). In each case, a 30 l sample was taken before the IP step, to determine the 
input RNA levels, and to verify transfection efficacy by immunoblot. The beads were 
washed 8 times with ice cold RNA co-IP wash buffer and retained RNA was extracted 
using the RNeasy Mini kit (Qiagen, Hilden, Germany). The on-column genomic DNA 
digestion step was included. Taq-Man chemistry-based sqRT-PCR was used to quantitate 
luciferase, PBGD and GAPDH levels in the input and output material. 
3.16 Analysis of CPEB-3 isoform expression pattern 
Total RNA purification and cDNA production were performed according to the 
manufacturers guidelines, using (respectively) RNeasy kit (Qiagen) and SuperScript III 
reverse transcriptase system (Invitrogen).  CPEB-3 was amplified using a set of primers 
flanking alternatively spliced region, yielding amplicons corresponding to different 
isoforms (Theis et al., 2003b). Obtained PCR products were purified from gel, T/A-
cloned into Topo-XL vector (Invitrogen) and sequenced. Sequences were aligned using 
Jalview software (Waterhouse et al., 2009). 
3.17 Semi-quantitative Real Time PCR (sqRT-PCR) 
3.17.1 SYBR Green sqRT PCR 
For verification of RNA co-IP results done with conventional RT-PCR, SYBR Green 
chemistry-based sqRT-PCR was performed (in a 2-step procedure). The RT-reaction     
(1st step) was done with Omniscript reverse transcriptase (Qiagen), using oligo-d(T)15 
for priming and up to 2 µg of total RNA as template, in a 20 µl total reaction volume. 
Prior to the RT reaction, the co-IP-input RNA amount was normalized to the 
concentration of the least abundant sample. For co-immunoprecipitated (output) 
material, normalization was not performed. SYBR Green PCR (2nd step) was performed 
using SYBRGreen 2x Supermix (Biorad) and 1 l of RT reaction mix was used as 
template in 25 µl total reaction volume.  Each reaction was done in duplicate. Relevant 
master-mixes were always prepared to minimize pipetting errors. The reactions were 
carried out in 96-well plates, in the IQ5 optical system (Bio-Rad). All primers were 
optimized for use at an annealing temperature of 59°C. See Tab. 3-26 and 3-27 for 
(respectively) the reaction setup and temperature profile. The appearance of primer 
dimers was ruled out by melt curve analysis. Data was analyzed using Ct method 
using human -actin gene as a reference.  
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Reagent Amount 
Stock 
concentration 
2x SYBR Green 
Supermix 
12.5 l 2x 
Template cDNA 1 l variable 
Primer mix (F+R) 1 l 10M each  
ddH2O 10.5 l n/a 
Total volume 25 l  
Tab. 3-26: SYBR Green sqRT-PCR reaction mixture. 
 
3.17.2 Taq-Man sqRT PCR 
 
Temp. Time 
No. of 
cycles 
95oC 5 min  
95oC 30 s     
   x 40 59oC 30 s 
72oC 30 s 
55-95oC 
(+0.5oC/cycle) 30 s 
    
   
  x 81 
Melt curve 
Tab. 3-27: SYBR Green sqRT-PCR  
temperature profile. 
TaqMan sqRT-PCRs were performed as a 2-step procedure. The RT-reaction (1st step) 
was done with SuperScript III reverse transcriptase (Invitrogen), using up to 2 g of 
total RNA template, and 250 ng of random hexamers for priming, in a 20 µl total reaction 
volume. Prior to the RT-reaction, the RNA amount was normalized to the concentration 
of the least abundant sample (except for co-immunoprecipitated material, when 
normalization was not performed). Taq-Man reaction (2nd step) was performed using 
Gene Expression Master Mix (Applied Biosystems), and 0.5 l of RT reaction mix was 
used as template in 12.5 µl total reaction volume. Each reaction was done in duplicate. 
The reactions were carried out in Optical 384-Well Reaction Plate PCR plates (Applied 
Biosystems, Darmstadt, Germany) in the 7900HT Fast Real-Time PCR System (Applied 
Biosystems). See Tab. 3-28 and 3-29 for (respectively) the PCR reaction setup and 
temperature profile. Primer and probe design was done with Primer Express 3.0 
software, using default parameters. Primers overlapping exon-exon boundaries and 
with the lowest penalty score were chosen preferentially. All probes were labeled with 
TAMRA (3’-end) and 6-FAM (5’-end), unless specified otherwise. For each reaction, 
critical threshold cycle (Ct) value was determined using SDS 5.0 Software (Applied 
Biosystems). Efficiency of the primer/probes sets was calculated according to the serial 
dilution method (Higuchi et al., 1993; Souaze et al., 1996). All expression data represent 
the statistical mean of at least three independent experiments. Error bars are standard 
errors of the mean (SEM). Data was analyzed with Ct method, using human GAPDH, 
PBGD and/or -actin reference genes. In the co-IP experiments, mRNA retention by the 
bait proteins was calculated using normalized input mRNA value. 
Reagent Amount 
Stock 
concentration 
Gene Expression 
Master Mix 
6.25 l 2x 
Template cDNA 0.5 l variable 
TaqMan Assay 0.5 l primers: 10 M; probe: 5 M  
injH2O 5.25 l n/a 
Total volume 12.5 l  
Tab. 3-28: TaqMan sqRT-PCR – reaction mixture. 
Temp. Time 
No. of 
cycles 
50oC 2 min  
95oC 10 min  
95oC 15 s 
     x 40 
60oC 60 s 
Tab. 3-29: TaqMan sqRT-PCR 
temperature profile. 
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3.17.3 Conventional RT-PCR 
The reverse transcription (RT step) was done as described in section 3.17.2. The PCR 
step was performed with the Platinum Taq hot start polymerase system (Invitrogen), 
using 2 l of cDNA (RT reaction mix), in a C1000 thermal cycler (Bio-Rad). Obtained 
products were analyzed on 2% agarose gels stained with EtBr. 
3.18 In vitro phosphorylation 
3.18.1 Peptide synthesis 
CPEB-3-derived peptides were used as substrates for in vitro phosphorylation 
reactions. Peptide synthesis was done by Peptide Specialty Labs (PSL, Heidelberg, 
Germany). Peptides were synthesized with free carboxy termini, starting with an            
L-resin.  For PEG-biotinylated peptides, a Biotin-PEG-Nova Tag-resin (Merck) was used.  
Peptides were synthesized on a continuous flow peptide synthesizer according to the F-
moc chemistry by starting with the Fmoc-L amino acid attached to Wang resin (loading 
0.54 mM/g) and stepwise addition of the amino acids from C- to N-terminus. For 
facilitating the synthesis, pseudoproline dipeptides (Merck) were used for the following 
amino acids: N-T (9 and 10), S-S (20 and 21), D-S (32 and 33), and L-S (39 and 40). The 
other amino acids have been used as tBu-protected (D, E, S, T, Y),   Trt-protected (H, N, 
Q), and Pbf-protected (R) amio acids. The peptides were cleaved off the resin by a 
mixture of 95% TFA, 4% triethylsilane and 1% water at room temperature for a period 
of 2 h. During the cleavage process all protecting groups have been removed from the 
corresponding amino acids and the pseudoproline dipeptides have been converted to 
the corresponding L-amino acids. The raw material was lyophilized and purified by 
HPLC by dissolving the peptides in 30% acetonitrile in 0.1% aqueous TFA and passing 
the solution over a Gemini Axia (Phenomenex) column (260x25 mm). Peptides were 
eluted with 30-75% acetonitrile gradient in 0.1% TFA, in a time period of 20 min, at a 
flow rate of 20 ml/min. Eluted fractions have been analyzed by analytical HPLC using 
the same column material (100 x 4.6 mm) and the same gradient, and have been 
assessed by MALDI-TOF mass spectrometry. Fractions containing the material with the 
correct mass have been combined and lyophilized to yield the peptides as TFA-salts. 
3.18.2 In vitro phosphorylation reactions 
In vitro phosphorylation reaction mixes comprised active kinase: CaMKII or protein 
kinase A (PKA) catalytic subunit  (PKA-C), ATP, kinase buffer (all from New England 
Biolabs), and peptide substrate. CaMKII was activated in the presence of Ca2+ and 
calmodulin (refer to Tab. 3-30 for the respective setup). Peptide substrate, ATP, and 
enzyme amounts were optimized, depending on the nature of downstream assay: 
MALDI-TOF-based assay, PKLight assay and ADP-Glo assay (for respective reaction 
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setups refer to section 3.18.3, 3.18.4 and 3.18.5). Relevant master mixes were prepared 
whenever possible to minimize pipetting errors. Control reaction mixes included water 
instead of kinase (no-kinase control) or peptide (no-substrate control). 
reagent amount 
stock 
concentration 
CaMKII kinase 4 l 500U/l 
ATP 2 l 10 mM 
Calmodulin 2 l 12 M 
CaCl2 2 l 20 mM 
CaMKII buffer 2 l 10x 
water 8 l n/a 
total volume 20 l  
reaction conditions: 15min at 30oC 
Tab. 3-30: CaMKII preactivation reaction mix. 
3.18.3 MALDI-TOF – based phosphorylation assay 
MALDI-TOF (matrix-assisted laser desorption/ionization – time-of-flight) mass 
spectrometry (MALDI-TOF-MS) was used for qualitative determination of in vitro 
phosphorylation of peptide substrates (experiments were performed in the group of Prof. 
Hans-Georg Sahl, Institute of Microbiology and Biotechnology, Bonn). PKA and CaMKII 
phosphorylation reaction setups for MALDI-TOF-MS analysis were summarized in Tab. 
3-31 and 3-32, respectively. 
reagent amount 
stock 
concentration 
PKA kinase 3.75 l 
4 l 
500U/l 
ATP 10mM 
kinase buffer 4 l 10x 
peptide 8 l 500M 
water 20.25 l n/a 
total volume 40 l  
reaction conditions: 1 h at 37oC 
         Tab. 3-31: PKA phosphorylation for MALDI-TOF-based assay. 
reagent amount 
stock 
concentration 
CaMKII pre-activated mix 4 l 25U/l 
ATP 1 l 10mM 
CaMKII buffer 1.6 l 10x 
peptide 2 l 500M 
water 11.4 l n/a 
total volume 20 l  
reaction conditions:        1 h at 30oC 
   Tab. 3-32: CaMKII phosphorylation for MALDI-TOF assay. 
Prior to the MALDI-TOF-MS analysis, phosphorylation reaction mixes were desalted 
on the C18 resin-packed pipette tips (ZipTips) (Millipore). The following steps were 
performed via slowly aspirating and dispensing the solution through the C18 resin: 
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ZipTip was equilibrated with 0.1% TFA and an aliquot (~6 l) of peptide-containing 
reaction mix was applied. The ZipTip was washed with excessive volume of 0.1% TFA. 
C18-bound peptides were eluted with 5 µl of the matrix, and applied on the spot of a 
ground steel MALDI target plate using a dried droplet method. As the matrix -HCCA 
saturated in TA (33.3% acetonitrile/0.1%TFA) was used. Samples were dried at room 
temperature analyzed on the Biflex III MALDI-TOF MS spectrometer (Bruker Daltonik 
GmbH, Bremen, Germany), using the following parameters: IS1: 19 kV, IS2: 17.2 kV, lens: 
8.8 kV, PIE: 200ns, gating: maximum. Spectra were recorded in the linear positive mode 
at a laser frequency of 20 Hz, within a mass range from 1,000 to 6,000 Da. For each 
spectrum, at least 300 laser shots in 30 shot steps were collected. Each sample was 
analyzed at least in duplicate. Visual estimation of the mass spectra, raw data smoothing 
and baseline subtraction was performed using the FlexAnalysis 1.0 software. Obtained 
data was analyzed and graphically presented using the GraphPad Prism 5.0 software. 
3.18.4 PKLight phosphorylation assay 
The PKlight assay (Lonza, Cologne, Germany) was used for quantitative analysis of in 
vitro phosphorylation by PKA (refer to Tab. 3-33 for the respective reaction setup). 
reagent amount 
stock 
concentration 
PKA kinase 3 l 50 U/l 
ATP 4 l 10 M 
kinase buffer 4 l 10x 
peptide 16 l 500 M 
water 13 l n/a 
total volume 40 l  
reaction conditions:    15 min at 37oC 
Tab. 3-33: PKA phosphorylation for PKLight assay. 
The assay was performed in white, flat-bottom, 96-well, polypropylene plates.  In 
each well, 20 l of the phosphorylation reaction (see section 3.18.2) was mixed with     
20 l of ATP detection reagent (kit component). The plate was gently vortexed and 
incubated for 10 min at RT. The firefly luciferase signal was measured on a luminometer, 
using 0.1 s integration time. Each reaction was performed at least in duplicate and each 
experiment was repeated at least 4 times. The data was normalized to „no-kinase” 
control levels and tested for significance with student’s t-test. 
3.18.5 ADP-Glo phosphorylation assay 
The ADP-Glo assay (Promega, Mannheim, Germany) was used for quantitative 
determination of in vitro phosphorylation by CaMKII (refer to Tab. 3.34 for the 
respective reaction setup). The assay was performed in white, flat-bottom, 96-well, 
polypropylene plates, according to the manufacturers recommendations. In brief, in 
each well, 10 µl of phosphorylation reaction mix was mixed with 10 µl of ADP-Glo. The 
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plate was vortexed, briefly centrifuged, and incubated at RT for 40 min. After that time, 
20 µl of Kinase Detection Reagent (KDR) was applied to each well and mixed by 
vortexing. The plate was incubated at RT for 40 min and firefly luciferase signal was 
measured on a luminometer, using an integration time of 0.5 s. Each reaction was 
performed at least in duplicate and each experiment was repeated at least 4 times. The 
data was normalized to „no-substrate” control levels and tested for significance with 
student’s t-test. 
reagent amount 
stock 
concentration 
CaMKII pre-activated mix 4.5l 25U/l 
ATP not incl. n/a 
CaMKII buffer 1.55l 10x 
peptide 8l 2mM 
water 5.95l n/a 
total volume 20l  
reaction conditions:          1 h at 30oC 
Tab. 3-34: CaMKII phosphorylation for ADP-Glo assay. 
3.19 Stimulation of HEK-293 cells 
HEK-293 cells were seeded on 6-well TC-culture plates (800.000 cells/well) and 
transfected on the next day with 3µg of CPEB3a-EGFP plasmid, using Lipofectamine 
2000 reagent (Invitrogen). 50 mM forskolin stock was prepared in DMSO. 24 h post 
transfection medium was supplemented with 50 µM forskolin (New England Biolabs, 
Frankfurt, Germany) or identical amount of DMSO without forskolin in case of control 
wells. After 1h incubation, cells were washed with ice-cold PBS and lysed in PIL buffer 
supplemented with protease and phosphatase inhibitors. Lysates were sonicated for 
10min. Supernatants were collected after 10min centrifugation at 10.000 g at 4oC. Total 
protein content was assayed with a BCA kit (Pierce) and 10-100 g of total protein per 
loading was used. Lysates were mixed with denaturing sample buffer and heated for 5 
min at 95oC. Immunoblot procedure and analysis was performed as described in section 
3.12, except that membranes were blocked with 5% BSA (instead of milk powder) in    
TBS-T buffer, pH 7.4, at 4oC, and incubated O/N at 4oC with custom-made primary            
phospho-CPEB-3a antibody (Eurogentec). 
3.20 Brain tissue dissociation and FACS sorting 
For analysis of CPEB expression in primary microglia and enzymatic tissue 
dissociation procedure follow by FACS cell sorting was applied. To visualize microglial 
cells, a transgenic mouse line CX3CR1GFP/GFP (Jung et al., 2000) was used. A CX3CR1GFP/GFP 
parent was bred with C57BL/6 to obtain 100% heterozygous litter. To visualize NG2 
cells and astrocytes simultaneously from one litter, homozygous NG2kiYFP/kiYFP mice 
(Karram et al., 2008) were crossbred with Cx43kiCFP/+ (Degen, Dublin et al., unpublished) 
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to generate double transgenic littermates, expressing YFP in all and CFP in 50% of the 
progeny. Obtained littermate animals were sacrificed at postnatal day 5. Brains were 
surgically removed and placed in ice-cold PBS. Meninges were removed and the brain 
was dissociated with trypsin-based Brain Tissue Dissociation Kit (Miltenyi Biotec), 
according to the manufacturer’s protocol. Dissociated cell suspension was diluted to     
~5 x 106 cells/ml. An aliquot was stained with APC-coupled anti-CD11b antibody. The 
cell suspension was filtered through 70 M pore size cell strainer and GFP+ cells were 
FACS-sorted. Sorted cells were centrifuged and total RNA was isolated using RNeasy 
mini kit (Qiagen) with on-column gDNA removal. 
3.21 RNA purification 
Total RNA was isolated using RNeasy mini kits (Qiagen) with on-column gDNA removal. 
Cells were lysed in 350 µl RLT buffer supplemented with β-mercaptoethanol (1% v/v final 
conc.) and disrupted with a 27G needle. Total RNA was eluted with 20-30 µl of TE-buffer, 
depending on the expected yield.  
3.22 In vitro transcription 
To allow for T7 polymerase-driven in vitro transcription of a luciferase reporter gene, 
a T7 promoter was inserted into the  pGL4.75[luc+/CMV] and pGL4.75[hRluc/CMV] 
vectors, as described in section 3.9.2.2. Plasmid templates containing luciferase reporter 
appended with fragments 3’UTRs containing CPE elements (and their mutated 
counterparts) (see also section 3.9.2.3) were linearized with SalI restriction 
endonuclease and purified with DNA Clean-up kits (Qiagen). Transcription reactions, 
capping and polyadenylation were performed using mMESSAGE mMACHINE kit 
(Ambion, Darmstadt, Germany) following the manufacturer’s protocol. 1 µg of linearized 
plasmid DNA was used as a template. Obtained products were purified and recovered 
using the MEGAclear RNA Purification Kit (Ambion). The RNA concentration was 
determined by the absorbance measurement at 260 nm, using a Pearl 
NanoSpectrophotometer (Implen, Schatzbogen, Gemany). The size and integrity of 
obtained transcripts was verified with on-chip electrophoresis using Agilent 2100 
Bioanalyzer (Agilent, Waldbronn, Germany). RNA was kept on ice for immediate use, or 
frozen for long-term storage. 
3.23 Luciferase assay 
HeLa cells were seeded on 24-well TC culture plates and transfected on the next day 
with 50ng of in vitro-transcribed mRNA per well.  mRNA transfection was performed 
with Lipofectamine 2000 reagent (Invitrogen) according to the manufacturers’ protocol  
(0.5 µl of the lipofectamine per well was used). Five hours post transfection cells were 
Doctoral Thesis – Lech Kaczmarczyk Materials and Methods 
-45- 
washed 3x with PBS and lysed in the passive lysis buffer (Promega), supplemented with 
1000U of RNAsin (Promega) per 1 ml of the buffer; 100 µl of lysis buffer per well was 
used. To ensure complete lysis, plates were incubated at room temperature with orbital 
shaking for 10 min. After that time, a 50 µl aliquot of the sample was immediately mixed 
with 350 µl of RLT buffer (Qiagen) for RNA isolation for the Taq-Man chemistry-based 
sqRT-PCR determination of luciferase mRNA levels. RNA isolation was performed using 
RNeasy mini kits (Qiagen), with on-column gDNA removal, according to the 
manufacturers’ protocol. The remainder of the lysate was used to determine firefly 
luciferase reporter activity. Luciferase reactions were performed in 96-well, white, flat-
bottomed polypropylene plates. 20 µl of lysate was applied to the wells. Plates were 
analyzed on the Centro LB960 luminometer (Berdhold Technologies, Bad Wildbach, 
Germany) set for the following event sequence: 20 µl substrate (see section 3.1.1) 
injection, 2 s delay, and 1 s measurement. Experiment was repeated three times, each in 
triplicate. Each luciferase measurement was performed in duplicate. Values obtained 
were normalized to the luciferase reporter mRNA levels (GADPH and -actin genes were 
used as internal controls). Obtained data was tested for statistical significance using 
student’s t-test. 
3.24 Lentiviral infection of ESdM 
Lentiviral transfer vector of the 3rd generation, pFTM3GW (GenBank accession no. 
FJ797421) was used to deliver and express DN-CPEB1-4 and CPEB-3 genes in ESdM cells 
(see also section 3.9.5). HEK-293FT cells were used as a packaging cell line. Lentiviral 
packaging was achieved through chemical (Lipofectamine 2000) transfection of 4 plasmids. 
The cells were transfected at 90% confluence, on 14 cm TC-dishes. The lentiviral expression 
module (in the pFTM3GW) was co-transfected along with the 3 helper vectors pLP1 
(containing the gag-pol genes), pLP2 (containing the Rev gene) and pLP/VSV-g (containing 
the VSV-g gene) (all components of the ViraPower kit, Invitrogen). The vectors were mixed 
at 1:1:1:1 molar ratio, and 46 g of total DNA with 150 l of Lipofectamine per dish was 
used for transfection. Medium was collected after 48 and 72 h (second harvest), and filtered 
(0.45 μm pore size). For storage, viral particles were concentrated by 90-min 
ultracentrifugation at 25.000 rpm, and recovered by re-suspension in PBS (gentle shaking 
for 3-4 h at 4°C). ESdM cells were transduced at 80% confluence on 10 cm TC-dishes. Before 
addition of viral particles, ESdM cells were placed in N2-medium containing polybrene       
(10 µg/ml). Transduction was performed with concentrated particles or crude harvest 
(diluted 1:1 with N2 medium on the cells). After overnight incubation, medium was 
replaced with standard N2 culture medium. Transduced ESdMs were incubated for 
additional 72 h before GFP-fluorescent cells were FACS-sorted. 
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3.25 FACS cell sorting and analysis 
Transduced ESdM cells, primary microglia, NG2 cells and astrocytes were FACS 
sorted in the Flow Cytometry Core Facility, Institute for Molecular Medicine and 
Experimental Immunology, University of Bonn. Sorting was performed on a customized 
BD FACS DiVA (BD Biosciences, Heidelberg, Germany). EGFP was excited with a 488 nm 
(blue) solid state laser (200 mW), using a 530/30 nm bandpass emission filter. After 
sorting, selected populations of ESdM cells were brought back to culture by 
resuspending in N2 medium in T75 TC-flasks. Primary microglia were deep-frozen or 
immediately lyzed for RNA extraction using RLT buffer (Qiagen) supplemented with 1% 
(v/v) -mercaptoethanol. For FACS-sorting, cells were collected from the culture            
TC-dishes by scraping in PBS.  Live/Dead Far Red Fixable Dead Cell Stain (Invitrogen) 
was added at 1l/106 cells to discriminate dead cells. Cell suspensions were diluted to            
~5 x 106 cells/ml, and kept on ice until analyzed. Data was acquired using FACS Canto II 
flow cytometer (BD Biosciences) and analyzed using Diva 5.0 (BD Biosciences) and 
FlowJo 7.6 (Tri Star, Inc.) software. For astrocytes (Cx43ki-ECFP) and NG2 cells (NG2ki-
EYFP), respectively 488 nm (blue, 200 mW) and 403 nm (violet, 70 mW) were used. 
After FACS total RNA was isolated using RNeasy mini kit (Qiagen) with on-column gDNA 
removal. mRNA expression levels were determined using TaqMan qRT-PCR, on 7900HT 
Fast Real-Time PCR System (Applied Biosystems, Darmstadt, Germany), following 
manufacturer’s recommendations. 
3.26 Transgenic mice breeding and genotyping 
The quality-control of Cre-mediated gene deletion (section 5.6) was performed using 
Cx30/Cx43 double knockout mice (previously described by Wallraff et al., 2006). These 
mice were raised by cross-breeding the mice with astrocyte-directed Cx43 gene deletion 
(Theis et al., 2003a) with the mice bearing unrestricted deletion of Cx30 gene (Teubner 
et al., 2003). Astrocyte-directed of Cx43 deletion was achieved using the hGFAP-Cre 
transgene (Zhuo et al., 2001). The genotypes used were Cx30-/-;Cx43fl/fl:hGFAP-Cre 
(termed double knockout, or DKO mice), Cx30-/-;Cx43fl/fl (control mice). The mice were 
analysed at the age of 30-90 postnatal days. Mouse genotyping was performed by PCR. 
DNA was isolated from the tail tips as previously described (Laird et al., 1991). 
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4 Results 
4.1 Specificity of CPEBs to target mRNA  
4.1.1 Defining 3’UTR termini of selected CPEB targets 
The positioning of the CPE element with respect to the cleavage and polyadenylation 
site is a determinant of direction and magnitude of cytoplasmic polyadenylation  (Hake 
et al., 1998).  To define the functional cleavage and polyadenylation sites of CPEB target 
mRNAs, CaMKII, tPA and Cx43 (putative target), a 3’RACE was performed. For tPA and 
Cx43, results were unambiguous; however in case of CaMKII, the reaction yielded two 
distinct bands (Fig. 4-1).  
 
 
Fig. 4-1: 3’RACE results (CaMKIItPA and Cx43), as analyzed by agarose gel electrophoresis. 
Two distinct bands obtained in case of CaMKII suggest co-existence of long and short forms of 
mRNA (see also Fig. 5-8). 
 
Results of the tPA and Cx43 3’RACE products sequencing revealed 3’UTR termini 
matching the records in the NCBI (accession no. NM_008872 and NM_010288, 
respectively). In case of CaMKII, the longer form (upper band) corresponded with the 
NCBI sequence (accession no. NM_009792). However, the shorter form seemed to be       
a specific RACE product as well. Firstly, because there was the AATAAA hexanucleotide 
in close proximity to the polyadenylation site. Secondly, because the 3’cDNA end was 
located in the homologous position to 3’cDNA terminus of the rat sequence (according to 
the NCBI record, accession no. AB056125) (Fig. 4-2). A fragment of the rat CaMKII 
3’UTR, containing proximal and distal CPE elements, was found to be recognized by 
CPEB-1, CPEB-3, and CPEB-4 in electrophoretic mobility shift assay (EMSA) (Theis et al., 
in revision). In the short variant of the mouse CaMKII 3’UTR, the position of CPE 
elements with respect to the 3’UTR terminus (and the AATAAA hexanucleotide) was the 
same, as in the rat 3’UTR. Consequently, this shorter variant, and not the long one, was 
chosen for further interaction studies. 
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Fig. 4-2: Alignment of mouse CaMKII 3’RACE product sequences (long and short) with the 
rat 3’cDNA end. Two distinct bands obtained for CaMKII 3’RACE (Fig. 4-1) suggest co-existence of 
long and short forms of mouse CaMKII mRNA. Alignment with rat 3’UTR sequence (GenBank 
accession no. AB056125) shows, that the mouse short form terminates in the position homologous 
to where the rat sequence ends. Poly(A) hexanucleotides were shown in orange. CPE-elements 
were depicted in blue. Discrepancies between mouse and rat sequences were marked in rat 
sequence in grey. 
4.1.2 -catenin mRNA is specifically recognized by different CPEBs 
As already mentioned, all CPEBs have a distinct RBD, essential for mRNA recognition, 
comprising a ZiF and RNA-recognition motifs (RRMs) (Hake et al., 1998). Similarity 
between the RBDs of CPEBs 2-4 is high (>97%) (Theis et al., 2003b), suggesting 
overlapping target specificity between these proteins. On the other hand, the similarity 
between CPEB-1 RBD and CPEB-2-4 RBDs is considerably lower (<45%). -catenin mRNA 
was previously shown to be regulated by CPEB-1 (Jones et al., 2008). Regulation of this 
ubiquitous actin-binding protein implicates CPEB-1 in basic cell motility and adherence 
functions, as described in cultured astrocytes (Jones et al., 2008). We wanted to find out, if 
other members of the CPEB family modulate -catenin mRNA translation as well. 
Endogenous -catenin mRNA co-immunoprecipitated with CPEB-1 and CPEB-3 
proteins in transiently transfected HeLa cells (Fig. 4-3). As a negative control, 
immunoprecipitated material was tested for GAPDH mRNA (the GAPDH 3’UTR does not 
contain CPE-elements).  
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Fig. 4-3: Co-IP of endogenous CPE-containing mRNAs in HeLa cells. Endogenous -catenin mRNA       
co-immunoprecipitates with overexpressed CPEB-1 (left) and CPEB-3 (right) proteins, as shown by          
RT-PCR from the co-immunoprecipitated material; line 1 – -catenin; 2 – GAPDH; 3 and 4 – respective 
inputs of 1 and 2. 
Likewise, CPEB2 was specifically binding to the endogenous -catenin mRNA in HeLa 
cells (Fig. 4-4).  
  
Fig. 4-4: Endogenous mRNA Pull Down experiments in cultured HeLa cells transfected with 
recombinant CPEB2 protein variants. (A) Deletion of Zn2+ finger significantly reduces CPEB2-EGFP 
fusion protein binding to -catenin mRNA. (B)  The binding is CPE-specific, as shown by comparison of 
PBGD (not containing any CPEs) and -catenin 3’UTRs binding to FLAG-CPEB2 (graph on the right).           
EGFP-FLAG was used as a non-specific protein control (bait), to which the results were normalized (values 
set to 1 on the graph). *P<0.05, student’s t-test. 
The binding was mRNA specific, as shown via comparing porphobilinogen deaminase 
(PDGD) (not containing CPE-elements) and -catenin mRNAs retention by CPEB-2 bait 
protein. A full-length- and a Zn2+ finger-truncated variant of the CPEB-2 protein (both as 
EGFP fusion proteins) were additionally used to test the importance of the Zn2+ finger in 
mRNA binding. ZiF deletion significantly reduced the binding of -catenin mRNA. 
Results were normalized to the EGFP-FLAG fusion bait protein (non-specific protein 
control). Altogether, CPEB-2-4 are able to bind CPEB-1 protein targets, i.e. CaMKII,       
-catenin, and CPEB3 mRNAs (Theis et al., in revision) and the binding is ZiF-dependent. 
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4.1.3 CaMKII mRNA is specifically recognized by different CPEBs 
In neurons of the mouse visual cortex, CPEB-1 was shown to modulate the 
experience-dependent translation of CaMKII(Wu et al., 1998). CaMKII in turn, is a 
well-established player in synaptic plasticity (Lisman et al., 2002). Interestingly, CPEBs 
2-4 contain a putative CaMKII phosphorylation site (Theis et al., 2003b). Moreover, 
they are phosphorylated in vitro by recombinant kinase, as shown in the peptide 
phosphorylation assays (see section 4.3). This suggests that CPEBs might be activated by 
a protein, which is a CPEB target itself, resulting in a positive feedback loop. That might 
be one of the mechanisms underlying long term modifications of synaptic morphology 
and function occurring during LTP and/or LTD. Nonetheless, it was tempting to find out, 
if other members of CPEB family modulate CaMKII mRNA translation as well. 
Therefore I cloned the mouse CaMKII 3’UTR and performed co-IP experiments to 
compare the interaction of CPEB-1, DN-CPEB1-4 and CPEB-3 with CaMKII mRNA. For 
prey mRNA expression, a luciferase reporter vector appended with the 143bp fragment 
of the CaMKII 3’UTR, containing one consensus CPE (UUUUUUAAU) and one non-
canonical CPE (UUUAUU) was used (Fig. 4-5D). DN-CPEB1-4, CPEB-1 and CPEB-3 were 
used as bait proteins. HeLa cells were co-transfected with respective bait protein 
expression vector and the pGL4.75[luc+/T7/CMV] vector encoding firefly luciferase 
appended with mCaMKIIα 3’UTR (with WT or MUT CPEs). I was able to co-
immunoprecipitate mCaMKII 3’UTR with each of the three tested proteins (Fig. 4-5). In 
case of DN-CPEB1-4 and CPEB-1, conventional RT-PCR results were verified with 
SYBRGreen-based sqRT-PCR. For CPEB-3 co-IP, results were analyzed and quantified 
using TaqMan-based sqRT-PCR. In each case, I observed a decreased mRNA retention 
after replacing the wild-type (WT, with CPEs) fragment with the mutated one (MUT, 
without CPEs). This suggests that the binding is to a large extent CPE specific, and that 
the specificity of CPEB-1 and CPEB-3 is indeed overlapping. 
4.1.4 CPEB-3 mRNA is a CPEB target 
The CPEB3 3’UTR was another CPEB target tested in RNA co-IP experiments.                 
A 3’RACE (performed by Vamshidhar Vangoor, Institute of Cellular Neurosciences, 
University of Bonn) revealed existence of two CPEB3 mRNA transcripts, with the 
poly(A) site at a distance of 3.5 kb or 0.8 kb from the STOP codon (termed distal and 
proximal, respectively). In co-IP experiments (performed similarly as for the CaMKII 
3’UTR experiments), CPEB-1 and DN-CPEB1-4 proteins interacted with (i) the distal 
CPEB-3 3’UTR fragment (447bp, containing two consensus CPEs (UUUUAU) and one 
non-canonical CPE (UUUUCAU)) (Fig. 4-6) and (ii) the proximal CPEB-3 3’UTR fragment 
(271bp, with one canonical CPE) (Fig. 4-7). 
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Prey: 
mCaMKII 3’UTR 
 
Bait: 
CPEB-3 protein 
 
Fig. 4-5: CPEB1, DN-CPEB1-4 and CPEB-3 bind specifically to the mouse CaMKII 3’UTR. (A) Binding of 
CPEB-1 to mouse CaMKII shown by co-IPs: line 1 – co-IP of WT mCaMKII 3’UTR; 2 – co-IP of MUT 
mCaMKII 3’UTR (lacking CPEs); 3 – mock co-IP of WT mCaMKII 3’UTR with EGFP-FLAG fusion protein;       
4 - co-IP of GAPDH 3’UTR construct (not-containing CPEs); 5, 6, 7 and 8 – respective inputs of 1, 2, 3, and 4;     
9 – negative control (n.c.) (untransfected cell lysate). (B) Binding of DN-CPEB1-4 to mouse CaMKII shown by 
co-IPs: line 1 – co-IP of WT mCaMKII 3’UTR; 2 – co-IP of MUT mCaMKII 3’UTR; 3 – mock co-IP of WT 
mCaMKII 3’UTR with EGFP-FLAG fusion protein; 4, 5, and 6 – respective inputs of 1, 2, and 3; 7 – n.c. 
(untransfected cell lysate). (A and B) All bands represent RT-PCR for luciferase. SYBR Green sqRT-PCR 
quantitation of the corresponding immunoprecipitates was shown (data was normalized to the input control 
levels). (C) Binding of CPEB-3 to mouse CaMKII shown by co-IPs: TaqMan quantification of mCaMKII 
3’UTR co-IP with CPEB-3 protein. Data represent normalized mRNA retention, with GAPDH (control) 3’UTR 
retention set to 1. (D) Schematic of wild-type and mutated mCaMKII 3’UTR fragments used in A, B and C. 
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Fig. 4-6: CPEB-1 (A) and DN-CPEB1-4 (B), bind specifically to the CPEB3 3’UTR (fragment containing 2 
canonical CPEs, distal to coding region). (A, B): Line 1 – co-IP of WT 3’UTR; 2 – co-IP of MUT 3’UTR (lacking 
CPEs); 3 – mock co-IP of WT 3’UTR with EGFP-FLAG fusion protein; 4, 5 and 6 – respective inputs of 1, 2 and 
3; 7 – n.c. (untransfected cell lysate). All bands represent RT-PCR for luciferase. (A) SYBR Green sqRT-PCR 
quantitation of the corresponding immunoprecipitates was shown (data was normalized to the input control 
levels). (C) Schematic of wild-type and mutated fragments of CPEB3 3’UTR (distal) used in A and B. 
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Fig. 4-7: CPEB1 (A) and DN-CPEB1-4 (B) bind specifically to the CPEB3 3’UTR (fragment containing 
one canonical CPE element, proximal to coding region).  (A) Binding of CPEB1 to the proximal 3’UTR of 
CPEB3 shown by co-IP: line 1 – co-IP of WT 3’UTR; 2 – co-IP of MUT 3’UTR (lacking CPE); 3 – mock co-IP of 
WT 3’UTR with EGFP-FLAG fusion protein; 4, 5 and 6 – respective inputs of 1, 2 and 3; 7 – n.c. (untransfected 
cell lysate). All bands represent RT-PCR for luciferase. (B) Binding of DN-CPEB1-4 to the proximal 3’UTR of 
CPEB3 shown by co-IP: line 1 – co-IP of WT 3’UTR; 2 – co-IP of MUT 3’UTR (lacking CPE); 3 – mock co-IP of 
WT 3’UTR with EGFP-FLAG fusion protein; 4 - co-IP of GAPDH 3’UTR construct (not-containing CPEs); 5, 6, 7 
and 8 – respective inputs of 1, 2, 3, and 4; 9 – n.c. (untransfected cell lysate); SYBR Green-based sqRT-PCR 
quantitation of the corresponding immunoprecipitates was shown (data was normalized to the input control 
levels). (C) Schematic of wild-type and mutated fragments of CPEB3 3’UTR (proximal) used in A, B and C. 
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4.2 Translational regulation of the GluR2 AMPA 
receptor subunit by the CPEB-3 protein 
In cultured primary hippocampal neurons, siRNA-mediated knock-down of CPEB-3 
protein led to upregulation of the GluR2 AMPA-R subunit (Huang et al., 2006). The 
GluR2 protein plays a key role in modulating AMPA-R properties (Isaac et al., 2007), and 
thereby contributes to the multifunctional role of the AMPA-Rs in the CNS (Kessels and 
Malinow, 2009), (Derkach et al., 2007). As already mentioned, mice overexpressing DN-
CPEB1-4 display deficits in activity-induced translation, late-phase LTP and spatial 
memory formation (Theis et al., in revision). We wanted to explore the hypothesis that 
CPEB-3, via translational regulation of the GluR2 subunit, accounts for the 
electrophysiological and behavioral phenomena observed in DN-CPEB1-4 mice. To this 
end, we took advantage of the tet-off system (see section 1.8.3) to overexpress CPEB-3-
EGFP fusion protein in principal neurons. We used the CaMKII-tTA driver (Mayford et 
al., 1996) and the tetO-CPEB3-EGFP overexpressor (tetO-CPEB3-EGFP construct 
generation and immunohistochemical screening of founder animals was done by 
Vamshidhar Vangoor). We cross-bred the CaMKII-tTA and the CPEB3-EGFP-tetO 
transgenic mice, to obtain the CaMKII-tTA/CPEB-3EGFP-tetO double transgenic (DT) 
progeny and littermate controls. The mice were sacrificed at the postnatal age of               
3 months and the hippocampus, cortex and cerebellum were surgically dissected and 
analyzed by immunoblotting. Expression of the CPEB3-EGFP transgene was clearly 
detectable, as shown by immunoblots (Fig. 4-8A) of selected brain areas of DT mice. 
Expression in the cerebellum was much weaker compared to the cortex and the 
hippocampus, which was in line with the reported spatial pattern of CaMKII-promoter 
activity (Odeh et al., 2011). We then assessed the GluR2 protein levels in the 
hippocampus and observed a decrease of expression to 48.5 ± 9.2%, compared to single 
transgenic (tTA+/tetO-) littermate controls (DT: n=4, control: n = 4)  (Fig. 4-8B,C). This 
observation was in line with the previous findings (Huang et al., 2006). Nevertheless, 
the experiments by Huang et al. (2003) were performed in cell culture. Here, using the in 
vivo paradigm of a transgenic mouse, we further demonstrated the relevance of CPEB-3 
for the GluR2 expression, a protein critical for neuronal function. 
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Fig. 4-8: Neuron-specific overexpression of the CPEB-3 protein suppresses translation of the GluR2 
AMPA-R subunit. (A) Representative immunoblot of selected brain subregions (HC-hippocampus,       
COR-cortex, CB-cerebellum) showing overexpression of the CPEB3-EGFP transgene exclusively in double 
transgenic (DT) animals (CaMKII-tTA/tetO-CPEB3-EGFP). No expression was observed in the 
cerebellum, as expected from the spatial distribution of the CaMKII-promoter activity, and in single 
transgenic controls. For each sample, -tubulin was used as an internal control. (B) Representative 
immunoblot showing downregulation of the GluR2 protein in the hippocampus of the CPEB3-EGFP 
overexpressing mice (DT: tTA+/tetO+; control: tTA+/tetO-). GAPDH was used as an internal control for 
normalizing expression levels. (C) Densitometric analysis of the representative immunoblot shown in A. 
DT mice show hippocampal GluR2 levels decreased to 48.5 ± 9.2% of the littermate controls. DT: n=4, 
control: n = 4. (*) P<0.01 (student’s t-test). 
4.3 CPEB-3 is phosphorylated by PKA and CaMKII 
4.3.1 In vitro peptide phosphorylation assays 
A set of 43 amino acids-long peptides was synthesized to test if the putative 
phosphorylation site (serine residues S419 and S420) in CPEBs 2-4 (Theis et al., 2003b) 
undergoes phosphorylation. The peptides included wild-type CPEB-3a and CPEB-3b 
isoforms (respectively, containing and lacking phosphorylation consensus motif), as 
well as the serine-to-alanine mutants of CPEB-3a isoform peptide. An overview of the 
peptides used for experiments in this section is presented on Fig. 4-9. 
A 
B C 
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Fig. 4-9: Aligned sequences of the synthetic peptides used in in vitro phosphorylation experiments. 
Alternatively spliced exon (termed a-domain) was highlighted in yellow. Putative phosphorylation site 
was marked with an asterisk. 
For qualitative determination of phosphorylation, the a-isoform and the 
corresponding S419A/S420A double mutant were phosphorylated in the in vitro 
reaction, and then analyzed by MALDI-TOF-MS. Both, CaMKII, and PKA phosphorylated 
CPEB-3-derived peptides. PKA activity led to a mass shift of the a-isoform peptide peak, 
as would be expected by addition of one (80Da) or two (160Da) phosphate (Pi) groups 
(Fig. 4-10A). This may suggest that during the in vitro reaction, both serine residues 
(S419 and S420) are being phosphorylated by the enzyme. No shift was observed in case 
of the S419A/S420A double mutant peptide (Fig. 4-10B). For CaMKII phosphorylation, a 
mass shift was observed in case of the a-isoform peptide, and was equal to the molecular 
weight of one Pi group (Fig. 4-11A). No shift was observed in case of the S419A/S420A 
double mutant (Fig. 4-11B). 
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Fig. 4-10: MALDI-TOF-MS spectra of CPEB-3-derived peptides phosphorylated by PKA-C. 
(A) a-isoform peptide spectrum: the peak shift corresponds to incorporation of 1 or 2 phosphates. 
(B) S419A/S420A double mutant peptide spectrum: no shift was observed after phosphorylation.       
(A, B) orange trace – spectrum after phosphorylation; black trace – no-kinase control spectrum; 
m/z – mass to charge ratio. 
A 
B 
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Fig. 4-11: MALDI-TOF-MS spectra of CPEB-3-derived peptides phosphorylated by CaMKII.                          
(A) a-isoform peptide spectrum: peak shift corresponding to incorporation of 1 phosphate was 
observed. (B) S419A/S420A double mutant peptide spectrum: no shift was observed after 
phosphorylation. (A, B) orange trace – spectrum after phosphorylation; black trace – no-kinase control 
spectrum; m/z – mass to charge ratio. 
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To confirm the MALDI-TOF results, and to quantitatively compare the propensity of 
different peptide variants to phosphorylation, the PKLight assay (Lonza) was used for 
PKA reactions and the ADP-Glo assay (Promega) was used for CaMKII reactions. In 
addition to the peptides used for MALDI-TOF, the serine-to-alanine single mutants 
(S419A and S420A) and the b-isoform peptide were included in the analysis. This 
allowed determining, respectively, which of the two critical serine residues was 
phosphorylated preferentially, and if the alternative splicing affects the CPEB3 protein 
propensity for phosphorylation. The a-isoform, and the S419A, and S420A mutant 
peptides were phosphorylated by PKA-C kinase at a significantly higher rate compared 
to the S419A/S420A double mutant (Fig. 4-12). The observed phosphorylation in case of 
the b-isoform was not significantly different. PKA preferentially phosphorylated serine 
420, as shown by the decreased phosphorylation rate in case of the S420A mutant 
peptide compared with the S419A substitution (p<0.01). Importantly, no significant 
differences were observed between no-kinase and no-substrate control, to which the 
data was normalized. Quantitative results of the PKA phosphorylation are summarized 
in Fig. 4-12. Note that due to the nature of the PKLight assay (in which post-reaction ATP 
levels are a read-out) the measured signal is inversely proportional to the 
phosphorylation rate. 
 
Fig. 4-12: Quantitation of peptides phosphorylation by PKA-C (PKLight assay). The a-isoform, 
S419A, and S420A mutant peptides were phosphorylated at a significantly higher rate compared to the 
S419A/S420A double mutant, while the b-isoform phosphorylation was not significantly different from 
the double mutant. Serine 420 is phosphorylated preferentially, as shown by decreased phosphorylation 
rate in case of S420A mutant peptide compared with S419A substitution (p<0.01). Values were 
normalized to no-substrate control levels (not shown on the graph). Values show relative levels of unused 
ATP after the phosphorylation reaction. Error bars are SEM. *P<0.005, **P<0.001 (student’s t-test). 
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For CaMKII, the a-isoform mutant peptide was phosphorylated at a significantly 
higher rate than the S419A/S420A double mutant peptide and the b-isoform (p-values 
<0.001 and <0.01, respectively) (Fig. 5-13A). Serine 420 was phosphorylated 
preferentially, as shown by the decreased phosphorylation rate in case of the S420A 
mutant peptide compared with the S419A substitution (p-value <0.05) (Fig. 5-13B). 
Note that in case of CaMKII reactions, a different type of phosphorylation assay was 
used. This was necessary, as the CaMKII kinase required pre-activation (by 
phosphorylation) in the presence of excessive ATP levels. Such excessive ATP could 
interfere with the PKLight assay. Instead, an ADP-Glo assay was used, where the ADP 
(and not ATP) post-reaction level is the read-out parameter. In this case, the magnitude 
of the signal is directly proportional to the phosphorylation rate. 
 
Fig. 4-13: Quantitation of peptide phosphorylation by CaMKII (ADP-Glo assay).  (A) a-isoform is 
phosphorylated at significantly higher rate compared with b-isoform and S419A/S420A double mutant. 
(B) Serine 420 is phosphorylated preferentially, as shown by decreased phosphorylation rate in case of 
S420A mutant peptide. (A,B) Values show relative ADP levels after the phosphorylation reaction, 
normalized to no-substrate control levels (not shown on the graphs). Error bars are SEM. *P<0.01, 
**P<0.001, ***P<0.05 (student’s t-test). 
4.3.2 Generation of phosphospecific antibodies directed to CPEB-3a/c 
A phosphospecific CPEB-3a/c antibody directed to serine residues S419 and S420 
(pCPEB3-S419-S420) was generated by Eurogentec (Germany), as described in section 
3.11. The performance of the antibody was tested by immunoblotting. Both, the 
phosphospecific fraction (column flow-through obtained after the second purification 
step against non-phosphorylated peptide), and the non-phosphospecific fraction 
(corresponding eluate) were tested. As a test antigen, the PKA-phosphorylated                 
a-isoform peptide (see Fig. 4-9) was used. The phosphospecific antibody detected the 
phosphorylated form of the peptide, but showed no reactivity against the non-
phosphorylated control peptide (Fig. 4-14). 
A B 
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Fig. 4-14: Immunoblot test of the pCPEB3 S419/S420 polyclonal antibody raised against a synthetic 
phosphopeptide derived from the region flanking Ser419 in the CPEB-3a/c. A PKA in vitro-phosphorylated 
a-isoform peptide was used as a test antigen. Streptavidin-HRP, detecting biotynylated peptides, was used 
to control for equal loading. 
4.3.3 Phosphorylation of CPEB-3a by PKA in cultured cells. 
HEK-293 cells transiently overexpressing CPEB3a-EGFP fusion protein were subjected to 
a forskolin stimulation paradigm (50 µM for 1 h), following immunoblot assessment of 
CPEB3a-EGFP phosphorylation (Fig. 5-15A). Forskolin-treated cells showed a signal 
increment amounting to 654 ± 80% of untreated control levels (Fig. 4-15B). 
 
 
     1           2           3          4 
 
 
Fig. 4-15: CPEB-3a phosphorylation in cultured cells. HEK-293 cell line was transiently transfected with 
the CPEB-3a protein and (24 h post transfection) treated with 50µM forskolin (adenylate cyclase activator) 
for 1 h. (A) A representative immunoblot showing increased phosphorylation state of CPEB-3a protein after 
forskolin stimulation. Lysate in lane 2 was additionally treated with calf intestine phosphatase (CIP) and 
showed a modest decrease of signal as compared with the control lysate (lane 1). (B) Cumulative 
densitometric analysis of the immunoblots of the forskolin-treated (n=5) and control (n=4) HEK-293 cells. 
Values were normalized to mean control level, which was set to 100%. After stimulation relative 
phosphorylation increased to 654 ± 80% of control. -tubulin and -actin (not shown) were used to 
normalize for the total protein content. Error bars are SEM. *P<0.01 (student’s t-test). 
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4.4 Microglial CPEBs and their splice isoforms 
4.4.1 Microglial cell lines are positive for CPEBs 1-4 
To confirm expression of CPEB1-4 genes in microglial cell lines, ESdM and BV-2 cells, 
RT-PCR analysis, followed by immunoblot immunocytochemical staining were 
performed. On the transcript level, the cells were tested for the presence of CPEB1-4 
mRNA. The primers used for the analysis flanked the alternatively spliced region (in 
each of the CPEBs, resulting in multiple RT-PCR bands in case more than one isoform 
was present (Fig. 4-16A). All four CPEBs were detected. Mouse Whole Brain Marathon 
Ready cDNA (Clontech) was used as a reference sample. In case of CPEB2-4, the 
obtained splice isoform band pattern was different in the cell lines, as compared to the 
reference (whole brain cDNA). This may suggest, that (some) isoforms are specific for 
microglial cells, or at least point on quantitative differences in isoform distribution 
between the cell types. In addition, the presence of CPEB2-4 proteins in ESdM and BV-2 
cells was confirmed by immunoblot (Fig. 4-16B). CPEB1 was not detected probably due 
to insufficient affinity of the antibody used. 
 
 
 
 
 
Fig. 4-16: CPEB expression in microglial cell lines and mouse hippocampus. (A) RT-PCR of BV-2 
immortalized microglial cells and ES-cell derived microglia (ESdM) reveals expression of all 4 CPEB1-4 
transcripts in both analyzed cell types (n=2 experiments). Multiple bands observed correspond to 
different splice isoforms. -actin was used as a positive control (not shown). (B)  Immunoblot analysis of 
the abovementioned cell lines. CPEB-2-4 proteins were detected in both cell lines. CPEB-1 was not 
detectable, possibly due to insufficient specificity of the anti-CPEB-1 antibody used (not shown). 
A B 
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Immunocytochemical (ICC) staining of BV-2 cells showed immunoreactivity to CPEB1-4 
antibodies, confirming the RT-PCR and immunoblot results (Fig. 4-17). Immunoreactivity to 
CPEB-1 antiserum was lower, as compared with the CPEB2-4 antibodies. This may suggest 
that the affinity of the CPEB-1 antibody used is lower (as compared to CPEBs -2 to -4) and 
explain its suboptimal performance in the immunoblot analysis.  
 
Fig. 4-17: Immunofluorescent antibody staining of BV2-immortalized 
microglia for CPEB1-4. Cells showed immunoreactivity to antibodies against all 
four CPEB proteins. Scale bar: 50m. 
To detect and quantify the distribution of CPEBs 1-4 in mouse primary microglia, 
astrocytes and NG2 cells, enzymatically dissociated mouse brains were subjected to 
FACS cell sorting. To facilitate identification of microglial cells, transgenic mice 
expressing GFP in the fraktalkine receptor (CX3CR1) locus were used (Jung et al., 2000). 
Mice were sacrificed at postnatal day 5. Brains were removed and enzymatically 
dissociated using the trypsin-based Neural Tissue Dissociation Kit (Miltenyi Biotec). To 
minimize contamination with blood monocytes (positive for the CX3CR1 receptor as 
well), meninges were removed prior to the procedure. In case of primary microglia, 
detection specificity was validated by FACS, using allophycocyanin (APC)-coupled anti-
CD11b antibody (Fig. 4-18).  
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Fig. 4-18: Fluorescent-activated cell sorting (FACS) analysis of microglia from CX3CR1GFP/+ knock-in 
transgenic mice (Jung et al., 2000). GFP versus allophycocyanin (APC) dot-plot showing dissociated 
brain cells of CX3CR1GFP/+ knock-in transgenic mice stained with APC-coupled anti CD11b-antibody. APC – 
allophycocyianin (labelling of CD11b positive cells with APC-coupled monoclonal anti-CD11b antibody).  
After isolation of RNA from the sorted population, sqRT-PCR was performed, using 
Taq-Man primers/probes for CPEBs 1-4. All four CPEBs were detected in FACS-sorted 
primary microglia. Results are presented in Fig. 4-19. 
 
Fig. 4-19: sqRT-PCR analysis of relative expression of CPEBs -1 to -4 in FACS-sorted primary 
microglia. Total RNA was extracted from FACS-sorted microglial cells from mouse brain (postnatal day 5) 
and the relative expression of CPEBs -1 to -4 was analyzed using Taq-Man-based sqRT-PCR system. 
Highest level (CPEB4) was set to 100%. Error bars are SEM; n=4. 
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4.4.3 CPEB-3 isoforms containing the B-region were not detected in 
ESdM cells 
RT-PCR analysis of the CPEB-3 transcripts in Embryonic Stem Cells-derived Microglia, 
followed by sequencing of the obtained PCR products revealed expression of the b/d 
isoforms, but not the a/c isoforms. Note that the b-region, present in the a/c isoforms 
contains the putative phosphorylation consensus site. This region corresponds to exon 5 
in the CPEB-3 gene (accession no. NM_198300). Modulation of the rate of exon 5 
skipping during alternative splicing would affect the propensity of the cellular pool of 
CPEB-3 for phosphorylation (and activation). Lack of the a/c isoforms may be a cell 
culture-specific phenomenon. It is possible that skipping of exon 5 is a default 
alternative splicing setting for CPEB-3 in resting conditions, and the specific stimulation 
leads to inclusion of this exon. Therefore cultured cells, lacking the physiological 
signalling partners, might preferentially skip it (see also section 5.2). 
4.4.4 tPA mRNA is a CPEB target 
Sequence analysis of the tPA 3’UTR revealed the presence of CPE element(s) in the 
vicinity of the polyadenylation signal. tPA was previously described as a CPEB-1 target 
(Shin et al., 2004). Before testing new CPEB targets, I decided to confirm the interaction 
between CPEB-1 protein and tPA 3’UTR by co-IP. A terminal 215bp fragment of tPA 
3’UTR was used as bait (Fig. 4-20B). CPEB-1 co-immunoprecipitated the tPA 3’UTR WT 
fragment with significantly higher affinity than it did in case of the corresponding 
mutated 3’UTR, control bait protein (FLAG-EGFP), or control prey mRNA (GAPDH 3’UTR, 
not-containing CPE elements) (Fig. 4-20A).  
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Fig. 4-20: The CPEB-1 protein interacts with the tPA 3’UTR. (A) Co-IP of overexpressed 3’UTR derived 
from tPA luciferase reporter mRNA appended with wild-type (WT) or mutated (MUT) 3’UTR (TaqMan-based 
sqRT-PCR quantification using luciferase-gene specific oligonucleotides). FLAG-CPEB1 or FLAG-EGFP 
(control) fusion proteins were used as baits. (B) Schematic of wild-type and mutated 3’UTR constructs used 
in A. * P<0.05 (student’s t-test). 
4.5 Luciferase Reporter Assays to study                     
CPEB-mediated translational regulation 
The luciferase reporter assay was done to demonstrate the functional relevance of 
the CPEs in the tPA 3’UTR.  Experiments were performed on HeLa cells transfected with 
the in vitro-transcribed mRNA encoding the luciferase reporter construct. The 
constructs used contained the luciferase reporter Open Reading Frame (ORF) appended 
with the tPA 3’UTR in its wild-type form (WT) and with mutated CPEs (MUT). The in 
vitro transcription was driven by T7 polymerase, using the Message Machine T7 Ultra kit 
(Ambion) (see section 3.22). The schematic of the construct is depicted in Fig. 5-21. 
  
Fig. 4-21: Schematic of the tPA 3’UTR luciferase reporter constructs used in the luciferase reporter 
experiments. The T7 promoter drives expression of the luciferase reporter. The reporter coding 
sequence is appended with the tPA 3’UTR containing wild type or mutated CPEs, thereby allowing to 
assess their impact on gene expression.  
 
 
B 
B 
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The mRNA transfection was chosen to exclude the impact of the modifications of the 
3’UTR on nuclear polyadenylation, which would lead to changes in reporter expression 
unrelated to the CPEB-mediated cytoplasmic polyadenylation. Prior to transfection of 
the HeLa cells, the mRNA integrity was assessed by the Agilent 2100 Bioanalyzer, 
according to manufacturer’s protocol. The result of the analysis is shown in Fig. 4-22. 
 
Fig. 4-22: In vitro-transcribed mRNA integrity assessment by the Agilent 2100 Bioanalyzer. The 
quality of the wild type and mutated fragments was comparable (lane 1: wild-type, lane 3: mutated). The 
in vitro polyadenylation efficacy was demonstrated by the significant shift in fragment size (lanes 1 and 3: 
before polyadenylation, lanes 2 and 4: after polyadenylation). 
Normalized luciferase reporter activity in case of the wild-type construct amounted 
to 44% of the construct with mutated CPEs (Fig. 4-23). This shows, that in the presented 
experimental paradigm, the presence of CPEs leads to translational inhibition, probably 
mediated by the CPEB proteins endogenously present in HeLa cells (RT-PCR data, not 
shown). 
 
Fig. 4-23: Repression of luciferase reporter tPA 3’UTR construct expression by CPEBs.  Results of the 
reporter assay shows that the luciferase with the wild-type CPEs shows normalized activity amounting to 
44% of the mutated counterpart (with mutated CPEs). The effect is probably due to the expression of 
endogenous CPEBs in HeLa cells (RT-PCR data, not shown). Error bars represent SEM. (*) p < 0.05 
(Student’s t-test). 
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4.6 Expression of the DN-CPEB1-4 protein in ESdM 
cells 
To study the function of CPEBs in microglia, a lentiviral gene delivery system was used 
to stably overexpress the CPEB-1-EGFP, DN-CPEB1-4-EGFP and CPEB3-EGFP fusion 
proteins in ESdM cells (Napoli et al., 2009).  To this end, CPEB-1, CPEB-3 and DN-CPEB1-4 
ORFs were cloned into the 3rd generation lentiviral vector pFTM-3GW (section 3.9.5). 
Functionality of the expression cassette was proven by robust fluorescence of transiently 
transfected HeLa cells (not shown). The lentiviral particle production was performed with 
the ViraPower system (Invitrogen), using HEK-293 FT as a packaging cell line (section 
3.24). The transduction efficacy obtained (as determined by FACS) was 45% in case of the 
DN-CPEB1-4-EGFP and 55% in case of the control (EGFP) vector.  
Unfortunately, transduction with CPEB1-EGFP and CPEB3-EGFP constructs resulted in 
no or barely detectable signal, respectively. For CPEB3-EGFP, the transduction efficacy 
was considerably lower, compared with EGFP and DN-CPEB1-4. The fluorescence 
intensity of transduced cells was hardly distinguishable from background noise and cell 
auto-fluorescence. Analysis of the CPEB3-EGFP infected ESdM cells on a flow cytometer 
did not allow for defining any clear GFP-positive population. Taking this into account, the 
experiments with the CPEB1-EGFP and CPEB3-EGFP lentiviral transduction were 
discontinued at this stage.  
To exclude from further culturing the cells not expressing the transgene, FACS-sorting 
was performed. Sorting gates were defined in the EGFP-channel, in a way that 80% of the 
brightest cells from the GFP-positive population were selected. Histogram overlays, 
showing GFP fluorescence distribution of the transduced cells and the negative (not 
transduced) controls, are shown on Fig. 4-24. In each case, a distinct population of GFP-
fluorescent cells was present. 
By comparing the forward scatter (FSC) versus side scatter (SSC) plots of the control and 
the infected ESdMs, it immediately became obvious, that transduced cells (both, EGFP-
positive and DN-CPEB1-4-EGFP-positive) had an altered morphology. They were larger 
(FSC-A median for EGFP-positive and DN-CPEB1-4-EGFP-positive populations 6.47 x 104 
a.u. and 6.01 x 104 a.u. respectively, compared with 2.82 x 103 a.u. for control cell 
population), as well as more complex/granular (SSC-A median for EGFP-positive and          
DN-CPEB1-4-EGFP-positive populations 1.03 x 104 a.u. and 1.28x 104 a.u. respectively, 
compared with 0.80 x 103 a.u. for control cell population). SSC/FSC plots of transduced and 
control ESdM cells were presented in Fig. 4-25. 
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Fig. 4-24: FACS-sorting of the transduced ESdM cells. Histograms showing GFP fluorescence 
distribution for the ESdM cells transduced with EGFP (A) and DN-CPEB1-4-EGFP (B). Grey filled trace - 
transduced cells; overlaid black line – negative controls. 
 
Control EGFP DN-CPEB1-4 
   
Fig. 4-25: Changed scattering properties of transduced ESdM cells. Forward scatter (FSC) versus side 
scatter (SSC) FACS plots of the control (A), EGFP-transduced (B) and DN-CPEB1-4-transduced (C) ESdM 
cells. Transduced cells appear as bigger and more granular/complex, compared with controls. In B and C, 
the GFP-positive population of cells was marked with an elliptical gate.  
After sorting, the cells were brought back to culture conditions and cultivated for five 
passages. After that time, a sample of cells was FACS-analyzed, to confirm that the 
transgene expression was sustained at the expected level. Cells were analyzed for GFP 
fluorescence. Viable cells were identified using the Live/Dead Far-Red Fixable Stain 
(Invitrogen). The fraction of GFP-positive cells in the viable cell population of the DN-
CPEB1-4- and EGFP-expressing cells was 93.5% and 98.8%, respectively (Fig. 4-26). 
Positivity for EGFP expression of nearly all cells was confirmed by fluorescence 
microscopy of living cells (Fig. 4-27). 
A B 
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Fig. 4-26: Evaluation of FACS-sorted ESdM cells. After 5 passages >90% of transduced cells remained 
positive for the transgene. The fraction of positive cells in the living cell population of EGFP- (A) and DN-
CPEB1-4-EGFP-expressing cells (B) was 98.8% and 93.5%, respectively. Grey filled trace – living cell 
population; overlaid black line – total cells (dead cells included). 
 
Fig. 4-27: ESdM cells after lentiviral transduction. Phase contrast and GFP fluorescence pictures of 
transduced EGFP (top) and DN-CPEB1-4 (bottom) ESdM cells. Scale bar: 50m. 
 
The CPEB-1 protein binds to the CPEs in the 3’UTR of tPA mRNA, as shown in the 
section 4.4.4. It was mentioned before that DN-CPEB1-4 is the N-terminally truncated 
variant of CPEB-1 protein, proven to functionally bind CPEB-1 targets: CaMKII and 
CPEB3 mRNAs (section 4.1.3 and 4.1.4, respectively). DN-CPEB functionally interferes 
A B 
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with CPEB function by constitutively repressing the translation of CPEB target mRNAs. 
Importantly, DN-CPEB1-4 protein was shown to be functional in vivo: overexpression of 
the protein in the principal neurons (the tet-off system, with the CaMKII-tTA driver) 
led to phenotypical changes on the molecular (translational regulation), cellular (LTP) 
and behavioral level (spatial memory) in transgenic mice (Theis et al., in revision). 
Therefore, after establishing a stable overexpression of the DN-CPEB1-4 protein in 
ESdM cells, we aimed at evaluating its impact on the putative microglial CPEB target – 
tPA. Immunoblot analysis showed no significant difference in the tPA protein expression 
between control cells (transduced with the EGFP vector) and the DN-CPEB1-4-
expressing cells (DN-CPEB: n=6, EGFP: n=6) (Fig. 4-28). 
 
  
Fig. 4-28: Expression of tPA protein in ESdM cells transduced with the DN-CPEB1-4. (A) Representative 
immunoblot showing expression of tPA protein levels ESdM cells transduced with DN-CPEB1-4 and EGFP 
(control). -actin and -tubulin (not shown) were used as the internal control for normalizing expression 
levels. To bands observed in case of tPA blot might result from the heterogeneous glycosylation of the 
protein. (B) Densitometric analysis of the immunoblot shown in A. The observed decrease of tPA protein 
expression to 79.1 ± 2.2% of the EGFP control levels was not statistically significant. DN-CPEB1-4: n=6, EGFP 
(control): n = 6. 
4.7 NG2 cells and astrocytes express all four CPEBs 
To visualize NG2 cells and astrocytes simultaneously from one litter, homozygous 
NG2kiYFP/kiYFP mice (Karram et al., 2008) were crossbred with Cx43kiCFP/+ (Degen, Dublin et 
al., unpublished) to generate double transgenic littermates, expressing YFP in NG2 cells 
and CFP in classical astrocytes. Mice were sacrificed at postnatal day 5, dissociated using 
the trypsin-based Neural Tissue Dissociation Kit (Miltenyi Biotec). After isolation of RNA, 
RT-PCR was performed, using Taq-Man sqRT-PCR primers/probes for CPEBs 1-4. All four 
CPEBs were detected in both, NG2 cell and astrocytes. Results for the NG2 cells and 
astrocytes are presented in Fig. 5-29 and 5-30, respectively. The comparison of NG2 cells 
and astrocytes with respect to CPEBs 1-4 expression was presented in Fig. 5-31.  
A B 
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Fig. 4-29: sqRT-PCR analysis of relative expression of CPEBs -1 to -4 in FACS-sorted NG2 cells. Total 
RNA was extracted from FACS-sorted NG2 cells from mouse brain (postnatal day 5) and the relative 
expression of CPEBs -1 to -4 was analyzed using Taq-Man-based sqRT-PCR system. Highest level (CPEB4) 
was set to 100%. Error bars are SEM; n=4. 
 
 
 
Fig. 4-30: sqRT-PCR analysis of relative expression of CPEBs -1 to -4 in FACS-sorted astrocytes. 
Total RNA was extracted from FACS-sorted astrocytes from mouse brain (postnatal day 5) and the relative 
expression of CPEBs -1 to -4 was analyzed using Taq-Man-based sqRT-PCR system. Highest level (CPEB4) 
was set to 100%. Error bars are SEM; n=4. 
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Fig. 4-31: Comparison of the relative expression or CPEBs 1-4 in astrocytes and NG2 cells. Total RNA 
was extracted from FACS-sorted astrocytes and NG2 cells from mouse brain (postnatal day 5) and the 
relative expression of CPEBs 1-4 was analyzed using Taq-Man-based sqRT-PCR system. In each graph the 
higher of the two values was set to 100%. Error bars are SEM; n=4. 
4.8 Cx43 is a novel CPEB protein target 
Sequence analysis of Cx43 3’UTR revealed the presence of a CPE element overlapping 
with the AAUAAA hexanucleotide, suggesting a strong translational inhibition (Pique et 
al., 2008). Unlike to tPA, there was no experimental evidence to date that Cx43 mRNA is     
a CPEB target. With an approach similar to the one used to confirm the interaction 
between CPEB-1 and tPA mRNA, the putative interaction between CPEB-1 and Cx43 
3’UTR was tested. As prey, we used the luciferase construct appended with a 202bp 
terminal fragment of Cx43 3’UTR, containing wild-type (WT) or mutated (MUT) CPE (Fig. 
4-32B). Similar to tPA, CPEB-1 co-immunoprecipitated the Cx43 3’UTR WT fragment with 
significantly higher affinity than it did in case of the corresponding mutated 3’UTR.             
A control bait protein (FLAG-EGFP) did not interact with the Cx43 3’UTR (Fig. 4-32A). 
 
B 
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Fig. 4-32: CPEB-1 protein interacts with the Cx43 3’UTR. (A) Co-IP of overexpressed 3’UTR derived 
from Cx43 luciferase reporter mRNA appended with wild-type (WT) or mutated (MUT) 3’UTR 
(TaqMan-based sqRT-PCR quantification using luciferase-gene specific oligonucleotides). FLAG-CPEB1 
or FLAG-EGFP (control) fusion proteins were used as baits. * P<0.05, ** P<0.01 (student’s t-test); n=3. 
(B) Schematic of the wild-type and mutated 3’UTR constructs used in A.  
4.9 Quality control of astrocyte-directed Connexin43 
conditional gene deletion 
4.9.1 Cx30/43 DKO mice require a quality control for experimental 
validation 
The hGFAP-Cre transgene (Zhuo et al., 2001) has one important drawback: a variable 
recombination efficacy caused by spontaneous downregulation (or loss) of Cre expression 
(Requardt, Kaczmarczyk et al., 2009). This critical limitation required developing a reliable 
method of quality control in the transgenic animals. Here we embarked on assessing the 
hGFAP-Cre in mediating recombination in the conditional KO of Cx43 in Cx30-/-;Cx43fl/fl mice 
(Cx30/43 DKO mice). We developed a method in addition to a reporter gene activation, 
which is necessary due to the abovementioned variability of Cre expression, and which 
allows for assessing Cx43 ablation fidelity in Cx30-/-;Cx43fl/fl:hGFAP-Cre. The method is 
immunoblot-based and can be used post-experimentally.  
B 
A 
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4.9.2 Cx30/43 DKO mice display a variable Cx43 ablation status 
The brains of Cx30/43 DKO and littermate control mice were dissected. From one 
hemisphere, cerebellum, hippocampus and frontal cortex were isolated for Cx43 and Cre 
immunoblot analysis. The frontal tip of the cortex and cerebellum of the remaining 
hemisphere were used for DNA isolation to perform PCR analysis for i) the presence of the 
hGFAP-Cre transgene (Theis et al., 2003a), ii) the recombined Gja1 flox allele (called 
Cx43del) allele (Theis et al., 2001) and iii) the non-recombined Gja1 flox (called Cx43 flox) 
allele (Theis et al., 2001). The remaining part of the hemisphere (containing the dorsal 
hippocampus) was used for (immuno-)histochemical detection of the recombination-
activated β-galactosidase reporter. In addition, immunofluorescence analysis and 
immunoblotting for Cre recombinase were performed, to correlate its expression with the 
Cx43 ablation status. All three methods for monitoring recombination events were 
applied, i.e. immunoblot to assess recombination-mediated ablation of Cx43, PCR to 
examine recombination of the Cx43 flox allele and (immuno-) histochemistry to monitor 
recombination-activation of the reporter replacing Cx43 (immunohistochemistry was 
performed by Pavel Dublin, Institute of Cellular Neurosciences, Bonn, Germany). 
Immunoblot experiments with hippocampal lysates showed that in 6 DKO mice from          
2 different litters (Fa, Fb), efficient hGFAP-Cre mediated loss of Cx43 expression occurred 
(Fig. 4-33A). Residual expression amounted to 4.4 ± 0.8% of the mean level observed in 
Cx30-/-;Cx43fl/fl control littermates (DKO: n=6; control: n=5). This was in line with 
previous reports (Theis et al., 2003a; Theis et al., 2004). In one remaining litter (Fc), out of 
the 4 putative DKO mice tested one did not show a decrease in Cx43 protein expression 
and 3 mice showed a partial decrease of Cx43 protein level (Fig. 4-33B). The mean 
decrease of Cx43 protein expression in hippocampus for all pseudo DKO mice tested 
amounted to 61.8 ± 21.0% of control (DKO: n=4; control: n=4; Fig. 4-33D). Interestingly, 
faithful hGFAP-Cre mediated recombination (or lack thereof) occurred independently of 
gender and was consistent and reliable within individual litters. This means that 
littermates can be used as sentinels to pre-experimentally assess hGFAP-Cre activity by 
immunoblotting for Cx43. Using the cerebellar material, it was examined whether the 
occurrence of faithful recombination or inefficient Cre activity was consistent across 
different litters from the same parents and across generations, that is, if pseudo DKOs 
were generated by pseudo DKO parents. 16 DKO animals, 2 each from 8 breedings and the 
corresponding 8 parental DKOs were analyzed. The parental DKO animal giving rise to the 
pseudo DKO litter Fc (Fig. 4-33B) turned out to be a pseudo DKO mouse, as did the mice 
from the second tested litter from the same breeding pair. Another litter from a separate 
breeding pair contained pseudo DKO mice, and the corresponding parent was likewise        
a pseudo DKO. The other six breeding pairs generated offspring with faithful and efficient 
deletion. Interestingly, two of the parents were pseudo DKOs, yet they gave rise to DKO 
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offspring (immunoblot data not shown, but included in the densitometric analysis in       
Fig. 4-33E). Consequently, the deletion status of siblings seems to be a better indicator for 
Cre efficacy than the deletion status of the parents.  
 
 
 
Fig. 4-33: Assessing the efficacy of hGFAP-Cre by immunoblot analysis for Cx43. (A) Two litters (Fa 
and Fb) displayed greater than 95% loss of Cx43 protein expression in Cx30-/-;Cx43fl/fl:hGFAP-Cre mice 
compared to Cx30-/-;Cx43fl/fl littermates. (B) In another litter (Fc), pseudo DKO mice (‘‘+’’; #2, 4, 6, 8) 
showed an average decrease in Cx43 protein expression to about 62% of control levels. ♂- male; ♀ - 
female. (C and D) Densitometric analysis of the immunoblots shown in A and B, respectively; (*) P < 0.001 
(student’s t-test). (E) Comparison of mean cerebellar levels of Cx43 protein expression in DKO and pseudo 
DKO mice; (**) P < 0.0001 (Mann–Whitney test). 
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4.9.3 Cx43 ablation status in Cx30/43 DKO mice is homogeneous 
across brain areas 
As a next step, we tested by immunoblot analyses, whether faithful recombination or 
lack thereof occurred in a homogeneous fashion across brain areas and found that in 
hippocampus, frontal cortex, and cerebellum recombination was similarly efficient within 
individual mice of the DKO type and similarly inefficient within individual mice of the 
pseudo DKO type (Fig. 4-34A, B). When normalized to the respective, brain area-specific 
Cx43 levels of controls (n = 4), the residual Cx43 levels of DKO mice (n = 3) were higher in 
cortex 6.9 ± 0.7% and cerebellum 8.2 ± 1.6% compared to hippocampus 3.7 ± 0.4%. This 
may be due to the presence of leptomeningeal cells (difficult to separate from the brain 
tissue during surgery) in the samples that are not targeted by hGFAP-Cre (Theis et al., 
2003a; Theis et al., 2004). Residual Cx43 protein levels of the pseudo DKO animals tested 
(n = 3) were much higher and were similar across brain areas within individual animals 
(Fig. 4-34B). This means that, in addition to the pre-experimental selection of DKO mice 
using littermates as sentinels, faithful recombination can also be investigated 
postexperimentally. This can be accomplished by assessing Cx43 ablation in brain areas 
(e.g. cerebellum), which were not immediately used for the experimental analysis (such as 
electrophysiological investigation of acute hippocampal slices). Cerebellar tissue seems to 
be a good choice for routine evaluation of hGFAP-Cre efficacy. Pseudo DKO mice showed a 
mean decrease of cerebellar Cx43 protein levels to 57.6 ± 8.4% of control, whereas DKO 
mice showed a decrease to 8.1 ± 0.8% of control levels (pseudo DKO: n = 9; DKO: n = 23; 
control: n = 17; Fig. 4-34E).  
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Fig. 4-34: Comparison of Cx43 ablation level across brain areas. (A) Immunoblots showing that within 
individual mice selected from litters Fa-c, the pattern of hGFAP-Cre mediated Cx43 ablation was similar 
across all brain regions examined (i.e., hippocampus, frontal cortex and cerebellum). A representative Cre 
immunoblot (hippocampus) shows the correlation of Cx43 ablation status with the abundance of Cre protein 
in all brain areas examined. +: active Cre; ‘‘+’’: partially active or inactive Cre; -: Cre not present.                       
(B) Densitometric analysis of Cx43 immunoblots shown in A. (*) P < 0.05 (Mann–Whitney test).  
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4.9.4 In Cx30/43 DKO mice Cx43 levels positively correlate with Cre 
expression 
By immunobloting, it was found that expression of Cre recombinase positively 
correlates with the extent of Cx43 ablation (Fig. 4-34A). When testing different brain 
regions from transgenic mice (Cx30-/-;Cx43fl/fl:hGFAPCre: n = 16; Cx30-/-;Cx43fl/fl control:   
n = 10), three subpopulations of animals were distinguished (Fig. 4-35). One class of mice 
showed residual Cx43 protein levels below 20% of control level (19 samples from                
9 animals;    Cx43 = 6.6 ± 0.8%). These mice (termed DKO) were used for normalization of 
Cre levels (Cre = 100.0 ± 3.3%). A second class of mice showed Cx43 levels between 20% 
and 80% of control level (12 samples from 5 animals; Cx43 = 50.0 ± 3.0%. These mice, 
termed half pseudo-DKOs, displayed Cre levels amounting to 15.4 ± 2.8% of DKO mice.        
A third class of mice displayed a Cx43 abundance above 80% of control level (five samples 
from two animals; Cx43 = 102.7 ± 4.8%). These mice, termed full pseudo-DKOs, displayed 
Cre levels amounting to 21.4 ± 1.5%. Please note that the values mentioned above are 
mean ± SEM while the error bars in Fig. 4-35 depict the range, that is, the maximal 
deviations from the mean. 
 
Fig. 4-35: Correlation of Cx43 and Cre protein levels. Densitometric analysis of Cx43 and Cre 
immunoblots, showing the correlation of Cx43 ablation with Cre recombinase expression. Data points 
represent three distinct subpopulations of Cx30-/-;Cx43fl/fl:hGFAP-Cre animals, which were separated on 
the basis of their Cx43 ablation status. Values for hippocampus, frontal cortex, and cerebellum were 
pooled and the mean was calculated. Bars represent the highest and the lowest value for each group. Note 
that there was no overlap of data obtained for DKOs vs. pseudo DKOs. 
The results of the PCR analysis to monitor the recombination of the Cx43 flox allele in 
frontal cortex and cerebellum were consistent with the immunoblotting (for details see 
Requardt, Kaczmarczyk et al., 2009).  
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5 Discussion and Conclusions 
5.1 CPEB expression in mouse brain 
CPEBs 1-4 are present in major brain cell populations: neurons (Theis et al., 2003b), 
astrocytes, NG2 cells, and microglia. CPEBs1-4 were detected in microglial cell lines: BV-2 
cells and ESdMs (immunoblot, ICC, RT-PCR) as well as the primary microglia from          
FACS-sorted brain dissociates (sqRT-PCR). This is in fact the first attempt to look at CPEB 
expression in microglial cells. CPEB-1 on the Western blot level was barely detectable (not 
shown), which may be explained by the low specificity of the antibody used (custom 
made, Eurogentec). Detailed analysis of CPEB-3 isoforms in ESdM cells revealed 
expression of only selected isoforms. In case of CPEB-3 and CPEB-4, only isoforms lacking 
the B-region were found expressed. It cannot be ruled out that these isoforms were not 
detected due to the limitation of the analysis used. To analyze expression of the different 
CPEBs (and their isoforms), a set of primers flanking the alternatively spliced region of 
each CPEB was used. The amplicon length varied between 144nt and 347nt, depending on 
the isoform amplified. Due to insufficient resolution of the DNA electrophoresis in that 
range, and as small as 24nt (B-region size) difference between isoforms, the PCR products 
were cumulatively (all obtained products) purified from gel and T/A-cloned. During T/A 
cloning of multiple PCR products, some PCR fragments may tend to ligate preferentially 
compared to others. Especially shorter fragments (i.e. the fragments lacking B- and/or      
C-domain) may ligate preferentially, leading to a bias in the outcome. To reliably dissect 
the isoform expression in different cell types, a high resolution DNA electrophoresis on 
polyacrylamide gel should be used. For semi quantitative assessment of isoform 
distribution in tested material, a DNA capillary electrophoresis should be applied, or 
selected isoform-specific Taq-Man sqRT-PCR primer and probe sets should be designed. 
Another likely explanation for the failure to detect certain isoforms in ESdM cells is the 
discrepancies occurring between the cultured cells (even primary cells) and the cells in 
vivo. Although ESdM cells show a clear microglial phenotype (Napoli et al., 2009), they 
cannot be regarded as cells in the in vivo state, for they are derived from stem cell 
precursor cells in laboratory conditions. Thereby, the differentiation stimuli are limited 
and not physiological. As a consequence, phenotypical differences between these cells and 
their in vivo counterparts will unavoidably be present. Using FACS cell sorting, primary 
NG2 cells and astrocytes were purified from trypsin-dissociated mouse hippocampi          
(at postnatal day 5). Analysis of RNA purified from the FACS-sorted material revealed 
expression of all four CPEBs, with the CPEB-4 transcripts being the most abundant in both 
analyzed cell populations (see Fig. 4-29 and 4-30). 
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5.2 Phosphorylation and alternative splicing of CPEB-3 
The CPEB-3 protein in mouse brain occurs in four splice isoforms, termed a, b, c, and 
d, differing by the presence (or absence) of the so called B-region and C-region (see        
Fig. 5-1) (Theis et al., 2003b). The CPEB-3a isoform, containing both of the regions, is 
the most abundant. The occurrence of the B-region may have high physiological 
significance, as it harbors the PKA and the CaMKII phosphorylation sites. 
 
Fig. 5-1: CPEB-3 isoforms in mouse brain. Sequence comparison of a variable region in mouse CPEB-3 
(mCPEB-3). Two regions, termed B and C, are alternatively spliced, leading to expression of four isoforms. 
Consensus phosphorylation sites for PKA and CaMKII kinase is shown above the alignment and the 
putative phosphorylated residue (S419) is marked by an asterisk. 
The results of the in vitro peptide phosphorylation assays (see section 4.3.1) show 
that the a-isoform peptide (identical to the CPEB-3a/c sequence flanking the putative 
phosphorylation site) is (at least in vitro) indeed phosphorylated by PKA and CaMKII.  
The phosphorylation in case of the b-isoform peptide and the serine-to-alanine mutant 
was significantly reduced, as compared to the a-isoform. Moreover, HEK-293 cells 
transfected with CPEB-3a, followed by treatment with forskolin, showed a significant 
increase in the CPEB-3a phosphorylation level (see section 4.3.3). Therefore, a firm 
conclusion can be made that the presence of the B-region significantly affects the 
propensity of CPEB-3 protein for phosphorylation by PKA and CaMKII. 
Inducing seizures in mice by intraperitoneal injection of kainic acid (a potent agonist 
of non NMDA-type glutamate receptors), leads to upregulation of CPEB-3 mRNAs (Theis 
et al., 2003b). Interestingly, only the isoforms containing the phosphorylation consensus 
site (i.e. the B-region) are upregulated after kainate-induced stimulation (see Fig. 5-2). 
Epilepsy entails similar neuronal mechanisms as LTP, learning and memory. Therefore, 
it is conceivable that the CPEB-3 isoforms containing the B-region play an important role 
in these processes. 
 
Fig. 5-2: Isoform-specific upregulation of mCPEB3a/c isoforms in the 
hippocampus. (A) mCPEB-3a/c detected by Northern blot 2 h after intraperitoneal 
kainate injection. (B) corresponding image obtained using mCPEB-3b/d-specific 
probe (adapted from Theis et al., 2003b).  
C-region B-region 
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The sequence similarity between CPEBs -2 to -4 is substantial, especially in the RBD, 
where the proteins are almost identical (>98% similarity). It is therefore conceivable 
that they may share the propensity for being phosphorylated by the same set of protein 
kinases. Fig. 5-3 shows close to 100% similarity of the phosphorylation consensus site 
between the CPEBs -2 to -4.  
 
Fig. 5-3: Alignment of the regions flanking the phosphorylation site in CPEBs -2, -3, and -4. Sequence 
comparison shows, that although the flanking regions show moderate similarity, the phosphorylation 
consensus site is conserved between the paralogs. The putative phosphorylation site is marked with 
asterisk. Sequences aligned and analyzed using Jalview software. 
Additionally, the splicing pattern of CPEB-2 and CPEB-4 is similar to CPEB-3: they 
both contain the C-region and the B-region, and the latter contains the part of the 
phosphorylation consensus site. Each of the CPEBs -2 to -4 occurs therefore as B region-
containing isoforms (undergoing phosphorylation) and B region-lacking isoforms, which 
cannot be (at least at this particular site) phosphorylated. Studying the cell-type specific 
CPEB-3 phosphorylation mechanisms may shed new light on the physiological processes 
in which not only CPEB-3, but also CPEBs -2 and -4 are important players.  
 
The alternative splicing of CPEBs adds complexity to that task of unraveling CPEB 
function. In case of CPEB3, in addition to the four isoforms herein mentioned (a, b, c, d), 
additional isoforms have been found in mouse retina (Wang and Cooper, 2009). It 
cannot be ruled out that these, and possibly other not yet described variants are present 
in other cells. The exact physiological significance of the multiple CPEB isoforms, as well 
as their expression pattern in brain, awaits elucidation. 
5.3 CPEB-3 phosphorylation in cell signalling 
5.3.1 Neurons 
Regulation via phosphorylation by PKA and CaMKII places CPEB-3 (and, due to 
phosphorylation site conservation, also CPEB-2 and -4) as intracellular effector of 
signalling pathways. Synaptic plasticity, including hippocampal LTP, has been shown to be 
dependent on CaMKII (Atkins et al., 2005) and PKA activity (Sweatt, 1999; Duffy et al., 
CONCLUSION 
The presence of the B-region significantly affects the propensity of CPEB-3 protein 
to phosphorylation by PKA and CaMKII. 
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2001; Wikstrom et al., 2003; Gelinas et al., 2008). Both of these kinases are downstream 
targets of NMDA-R (Atkins et al., 2005). CPEB-1 protein - the first described and the most 
extensively investigated member of the CPEB family – is phosphorylated at the Thr171 by 
the Aurora A kinase, upon NMDA-R stimulation (Huang et al., 2002). CPEB-1 has also been 
shown to undergo phosphorylation by CaMKII (Atkins et al., 2004). Regulation of CPEB-1 
by phosphorylation and dephosphorylation by, respectively, CaMKII and Protein 
Phosphatase 1 (PP1) (see Fig. 5-4), is involved in sustaining hippocampal LTP (Atkins et 
al., 2005). This might be one of the explanations of LTP deficits observed in the CPEB-1 KO 
mice (Alarcon et al., 2004). 
  
Fig. 5-4: Model for bidirectional regulation of CPEB1 by CaMKII and PP1. Modest LTP induction 
(1x100Hz) stimulates Ca2+ influx through the NMDA-R (1). Ca2+ binds to calmodulin (CaM) and activates 
CaMKII (2) through autophosphorylation. Activated CaMKII phosphorylates CPEB-1 (3) to stimulate 
protein synthesis (4). The elevated levels of Ca2+ also activate protein phosphatase 2B (PP2B) (5), which 
dephosphorylates dopamine- and cyclic AMP-regulated phosphoprotein (DARPP-32), thereby activating 
PP1, to dephosphorylate CPEB-1 (6) and limiting protein synthesis. However, robust LTP (4x100Hz) 
further elevates Ca2+, stimulating adenylate cyclase (AC) (7) to generate cAMP. This activates PKA (8), 
which phosphorylates DARPP-32, thereby inhibiting PP1 to prolong CPEB phosphorylation and protein 
synthesis. Adapted from Atkins et al. (2005). 
CPEB-3a overexpression in neurons leads to the translational repression of the GluR2 
subunit of the AMPA-R (see section 4.2). Reports on the AMPA-Rs function in synaptic 
plasticity, and the role of the GluR2 subunit, has been extensively reviewed (Isaac et al., 
2007; Kessels and Malinow, 2009; Santos et al., 2009). Considering the overlapping 
target mRNA specificity of CPEBs -1 and -3, one cannot exclude that they may 
functionally complement themselves. Amongst the putative CPEB targets (binding to 
CPEB-1 and -3, see section 4.1.3) is the mRNA of CaMKII – the kinase which is itself a 
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CPEB-1 and -3 regulator, as well as a key player in synaptic plasticity (Wu et al., 1998; 
Lisman et al., 2002). The functional ablation of CPEB-1 to -4 in DN-CPEB1-4 transgenic 
mice (discussed in more detail in section 5.4) leads to deficits in LTP, learning and 
memory (Theis et al., in revision). Altogether, it is conceivable that CPEB-3 (and, due to 
sequence similarity, CPEBs -2 and -4) participates in synaptic plasticity mechanisms, 
and undergoes similar regulation, as CPEB-1 does (Fig. 5-5).  
 
Fig. 5-5: Hypothetical model of the translational regulation by CPEB-3 in synaptic plasticity. CPEB-3 
may be subjected to similar regulatory mechanisms, and control a similar set of targets, as CPEB-1 (see 
also Fig. 5-4). Adapted from Atkins et al. (2005), modified. 
 
5.3.2 Astrocytes and microglia 
CPEB-1 is involved in the control of astrocyte migration via translational regulation of 
-catenin mRNA (Jones et al., 2008). Since CPEBs -2 and -3 are binding to -catenin 
mRNA as well (see section 4.1.2), they likewise might be involved in translational 
regulation of this protein. Using RNA co-immunoprecipitation, herein I confirmed that 
HYPOTHESIS 
CPEBs -2 to -4 in neurons are regulated by PKA and CaMKII and are involved in 
NMDA-R-dependent forms of synaptic plasticity. 
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CPEB-1 is binding tPA mRNA (see section 4.4.4), an established neuronal CPEB target 
(Shin et al., 2004). tPA – a serine protease produced in brain by neurons and microglia – 
is a key player in synaptic plasticity (Samson and Medcalf, 2006). It has also been 
implicated in neurodegeneration following seizures in mouse brain (Tsirka et al., 1995). 
As mentioned before, in neurons, production of tPA is translationally regulated by CPEB-
1 protein (Shin et al., 2004). However, it has been shown that specifically tPA of 
microglial origin is a factor causing neurodegeneration (Siao et al., 2003). In this respect, 
it is worthwhile to investigate the binding of tPA mRNA by CPEBs 2-4 and the potential 
regulation of microglial CPEBs -2 to -4 by PKA. Microglial activation leads to activation 
of PKA. Hypothetically, PKA phosphorylation of CPEBs -2 to -4 in microglia might 
modulate the expression of tPA and thereby be crucial for microglial function in brain 
homeostasis and neurodegeneration in epilepsy. 
 
5.4 mRNA sequence specificity of CPEBs 
As mentioned in section 5.3, one of the putative functions of the CPEB-3 protein may 
be regulation of local protein synthesis in dendritic spines, in response to stimulation. 
Such mechanism has already been reported in case of CPEB-1 protein, involved in 
hippocampal LTP (Alarcon et al., 2004; Atkins et al., 2005). Interestingly, ablation of 
CPEB-1 gene leads to deficits in single train theta-burst stimulation (TBS)-evoked LTP 
and LTP evoked by 1 train of 100 Hz stimulation. LTP evoked by other stimulation 
paradigms (4 trains of 100 Hz stimulation, 1 Hz stimulation) were not affected (Alarcon 
et al., 2004). In contrast, overexpression of the DN-CPEB1-4 transgene in principal 
neurons (functionally interfering with all CPEBs constitutively repressing translation of 
CPE-containing mRNAs) did not result in changes in 1x TBS-evoked LTP,  but led to 
significant deficits in late form of LTP (L-LTP) induced by repetitive TBS stimulation 
(Theis et al., in revision). In addition, DN-CPEB1-4 mice showed deficits in captured LTP 
and modest enhancement of LTD induced by 1 Hz stimulation. The mRNA co-IP results 
showed that CPEB1 and CPEBs 2-4 have (at least to certain extent) overlapping 
specificity. Taken together, these results may suggest that in the CPEB-1 KO mice 
(Alarcon et al., 2004), the CPEBs -2 to -4 may compensate the deficits caused by CPEB-1 
gene ablation. The co-IP experiments of CaMKII, -catenin, and CPEB3 mRNAs have 
shown that despite the differences in the RBD of CPEB-1 and CPEB-3, they may both 
bind to the same sequences. As already mentioned in the section 5.2, CPEBs -2 to -4 have 
>98% identical RBDs. Therefore it is conceivable that CPEBs -2 and -4 share the binding 
HYPOTHESIS 
CPEBs are involved in regulation of microglial tPA production and thereby 
implicated in neurodegeneration following epileptic seizures. 
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specificity with CPEB-3. Consequently, it is possible that despite differences in the 
primary structure between CPEB-1 and CPEBs -2 to -4, they all could regulate 
translation of the same target mRNAs. 
 
 
5.5 Novel CPEB targets 
Two potential novel CPEB target mRNAs have been identified by RNA co-IP: the 
astrocytic gap junction protein Cx43 and the CPEB-3 itself.  The function of such                    
a positive feedback loop in case of CPEB-3 has to be elucidated. The hypothesis that 
increased translation of CPEB-3 after neuronal stimulation leads to increased inhibition 
of target mRNA, thereby modulating synaptic efficacy, awaits experimental evidence. In 
turn, the function of Cx43 in the CNS is better understood. Cx43 together with Cx30 
comprise the major astrocytic connexins (Nagy et al., 2004). They mediate                     
gap-junctional communication between astrocytes, thereby forming an interconnected 
syncytium. This was demonstrated by tracer-coupling experiments in transgenic mice 
with deletion of Cx30 (gjb6) and Cx43 (gja1) genes in astrocytes (the DKO mice, see also 
section 3.26) (Wallraff et al., 2006; Requardt, Kaczmarczyk et al., 2009). In these mice 
Cx30 is deleted in all cells of the body and the deletion of Cx43 is astrocyte-directed, 
achieved via the Cre/LoxP system using a hGFAP-Cre driver (Zhuo et al., 2001) (deletion 
of Cx43 in all cells of the body leads to embryonic lethality due to heart failure) (see also 
section 1.8). These mice display complete ablation of astrocytic coupling – a property 
that has made them extensively used in research of astrocytic gap-junctional 
communication in brain (patho)physiology (Wallraff et al., 2006; Rouach et al., 2008; 
Lutz et al., 2009). Interestingly, the DKO mice have a decreased threshold for epileptic 
seizure activity (Wallraff et al., 2006). This is in line with the suggested role of glia in K+ 
buffering and thereby regulation of K+ homeostasis in the CNS (Orkand et al., 1966). 
More recently, astrocytic networks were found to participate in metabolite delivery to 
neurons, essential for maintaining synaptic transmission (Rouach et al., 2008). 
Altogether, these finding suggest the dysfunctions of astrocytic connexins may either 
promote excitability by impairment of K+ homeostasis (fast onset effect) or decrease it 
by disruption of neuronal energy supply (delayed effect) (reviewed by Seifert et al., 
CONCLUSION 
mRNA sequence specificity of CPEB-1 and CPEB-3 is overlapping. 
HYPOTHESIS 
All CPEBs share similar phosphorylation regulatory mechanisms and regulate 
expression of an overlapping set of target mRNAs. 
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2010). Interestingly, both astrocytic gap junctions proteins - Cx43 and Cx30 - contain 
CPE elements in their mRNA 3’UTRs, as revealed by database sequence analysis. 
Immunohistochemical analysis of mice overexpressing CPEB-3a protein in astrocytes 
(tet-off system, hGFAP-driven tTA) show decreased expression of Cx30 and Cx43 
proteins in double transgenic animals, as compared with the single transgenic littermate 
controls (Vangoor et al., in preparation). Altogether, CPEB1, but possibly also CPEB2-4 
might be involved in translational regulation of the major astrocytic connexins. The 
functional implications of this findings are to be elucidated. 
5.6 The complexity of translational regulation by CPEB 
proteins 
As mentioned before, the sequence specificity of CPEB proteins is not restricted to        
a specific and well defined consensus sequence. It is conceivable, that variations in CPEs 
are tolerated and that the number, sequence and positioning of CPEs on the mRNA affect 
CPEB function. Pique et al. (2008) hypothesize that position of CPE elements, their 
number and distance from the AAUAAA hexanucleotide, determine the magnitude and 
direction of regulation for a given transcript. CPEB- may either interact with other 
(mRNA binding) proteins, thereby requiring specific spatial distribution of binding sites. 
Huang et al. (2006) argue that in case of CPEBs -3 and -4, mRNA secondary structure is 
necessary for CPEB binding. This however would be difficult to explain in view of the 
overlapping specificity of CPEB-1 and CPEB-3. EMSA experiments showing CPEB binding 
to target mRNAs (Theis et al., in revision) were usually performed on shorter fragments, 
which might not have the secondary structure they would have when incorporated into 
a full-length mRNA. In recent years several novel CPEB isoforms in addition to the ones 
previously reported (Theis et al., 2003b) have been described (Wang and Cooper, 
2009). In silico analysis of database information on CPEBs revealed existence of 
additional variants (Wang and Cooper, 2010). The significance of this variability, 
expression pattern of each isoform, and functions of alternatively spliced domains are in 
most cases to be disclosed. Unfortunately, such abundance of transcripts and protein 
variants renders the analysis with conventional molecular biology tools                           
(e.g. immunoblotting or immunocytochemistry) highly difficult. Herein, a function of the 
B-region in CPEB -2 to -4 regulation by phosphorylation is proposed. The significance of 
the phosphorylation in vivo awaits to be described. An intriguing hypothesis would be 
that some unknown splicing factors modulate CPEB function via changing the domain 
composition as a response to stimulation/activation. Addressing the question if such 
mechanism exists in neurons and are activated upon kainite stimulation would require 
employment of global proteomic analysis of stimulated hippocampal cultures and 
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transgenic mice. Lack of well-defined specificity of CPEBs is making analysis of mRNA 
binding in co-IP assay a difficult task. In this thesis I have established an RNA co-IP assay 
using a recombinant, FLAG-tagged protein. To discriminate between specific binding 
and unspecific background, the immunoprecipitated material was analyzed using                
a quantitative RT-PCR, and the data normalized to unspecific protein control levels. Still, 
the binding specificity of CPEBs require further investigation, and alternative in vitro 
binding studies may likely prove to be required for interpretation of the in vivo 
observations. 
5.7 Cre transgenic mice require experimental 
validation of floxed gene deletion 
As already mentioned (section 1.8.1), Cre-transgenes are not free of limitations. One of 
the problem occurring with hGFAP-Cre is the spontaneous downregulation (or loss) of Cre 
expression (Requardt, Kaczmarczyk et al., 2009). Several hypothetical mechanisms lying 
behind the heterogeneity of hGFAP-Cre mediated recombination were discussed and 
tested (Requardt, Kaczmarczyk et al., 2009). The results remained inconclusive, and the 
question about the cause of observed vagaries remains open. In section 4.9 an 
immunoblot-based recombination fidelity control method of hGFAP-Cre-mediated gene 
deletions was described. The method enables the selection and evaluation of knockout 
animals bearing the hGFAP-Cre transgene. The presented quality control method is 
strongly recommended when working with the hGFAP-Cre transgene. An identical or 
similar approach may be applied as an additional control to other GFAP-Cre transgenes, 
widely used in the glial field. Immunoblot-determined Cx43 deletion status in Cx30/43 
DKO mice was consistent within individual litters and breedings. Therefore, sibling can be 
used to initially determine the suitability of a given litter for experiments. Nonetheless, it 
is strongly recommended to post-experimentally validate the individual mice, to exclude 
the chances that observed phenotypical alterations are caused by incomplete 
recombination.  
Doctoral Thesis – Lech Kaczmarczyk Summary 
-89- 
6 Summary 
CPEBs are a family of evolutionary conserved auxiliary translational factors. They bind to 
CPEs in the 3’UTR of target mRNA and, by interacting with other members of the 
translational machinery, promote or decrease gene expression. Since the first description of 
CPEB protein as a key orchestrator of oocyte maturation in Xenopus Laevis, key functions of 
CPEBs in embryonic development, cellular senescence and synaptic plasticity have been 
described (reviewed by Richter, 2007). Local, postsynaptic modulation of synaptic efficacy 
is the most studied function of CPEBs in the CNS. However, the expression of CPEBs is not 
restricted to neurons and even 7% of total brain mRNAs possesses CPEs. Moreover, specific 
mRNAs are enriched in functionally distinct subcellular regions, like dendritic spines of 
neurons or complex cellular processes of astrocytes, where they might be translationally 
regulated. Herein, I embarked on further elucidating the role of CPEB translational 
regulators family in selected cell populations in mouse brain.  
In the first part of the work, the target mRNA specificity of different CPEBs was tested.       
I argued with the hypothesis that CPEBs -3 and -4 require mRNA secondary structure            
(a stem-loop) for target recognition (Huang et al., 2006). I showed that despite differences 
in the RBD primary structure, CPEB-1 shows a considerable sequence specificity overlap 
with CPEB-3 (and possibly, due to sequence similarity, with CPEBs -2 and -4 as well). This 
holds true for neuronal (CaMKII) and astrocytic (-catenin) CPEB targets (Theis et al., in 
revision). Additionally, RNA co-immunoprecipitation revealed two novel CPEB target 
mRNAs, encoding (1) an astrocytic gap junction protein (Connexin43) and (2) CPEB-3 
protein itself. 
In the second part of the thesis, CPEBs 1-4 gene expression in microglia, NG2 cells and 
astrocytes was assessed at the mRNA and protein level, confirming the ubiquitous nature of 
the CPEB expression. A more detailed analysis of CPEB-3 mRNA revealed expression of only 
certain isoforms of the protein in ESdM cells. Each CPEB family member occurs in several 
splice variants. Hitherto, only a handful of reports are dealing with the significance of 
alternative splicing of CPEBs. Interestingly, regulation of expression of CPEBs in neurons 
may happen in an isoform-specific fashion (Theis et al., 2003b). Seeing this as a highly 
intriguing phenomenon, I focused on CPEB-3, containing a putative kinase recognition site 
on the alternatively spliced exon 5. In a cell-free systems and in cultured cells, I showed that 
CPEB-3 is a target of PKA and CaMKII – both critical for LTP/LTD (Grey and Burrell, 2010), 
and that exon 5 harbors a consensus sequence required for kinase recognition. In vivo, in       
a transgenic mouse overexpressing CPEB3 protein in principal neurons of the hippocampus, 
I found a significant decrease in GluR2 AMPA-R subunit protein levels. In view of the above, 
the stimulation-induced phosphorylation of CPEB-3 may very well be a novel mechanism of 
translational modulation of synaptic plasticity. 
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In the third part, I embarked on unraveling the function of CPEBs in microglial cells, using 
ESdM cells (Napoli et al., 2009) as model system. I tried to test the hypothesis, that CPEB 
translationally regulates the production of microglial tPA – the major factor causing 
neurodegeneration following epileptic seizures in mouse brain (Tsirka et al., 1995). Using 
retroviral gene targeting followed by FACS of cellular populations, I tried to interfere with 
the microglial CPEB function by expressing a DN-CPEB1-4 transgene. DN-CPEB1-4 
expression was successfully established in ESdM cells. Despite that, I did not observe a 
significant impact of DN-CPEB1-4 overexpression on the microglial tPA production in 
cultured ESdM cells. 
In the final part of the thesis, I aimed at establishing a quality control method for Cre-
mediated gene deletions. Using Cx30-/-;Cx43fl/fl mice with hGFAP-Cre recombinase driver,     
I developed a reliable immunoblot-based tool for post-hoc control of recombination 
variability in hGFAP-Cre transgenic mice (Requardt, Kaczmarczyk et al., 2009). 
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7 Future Outlook 
7.1 Detailed analysis of CPEB expression 
In view of the recent findings describing new CPEB1-4 splice isoforms (Wang and 
Cooper, 2009; Wang and Cooper, 2010), the CPEB1-4 splicing pattern should be 
investigated in more detail. Using (1) single cell RT-PCR and (2) (laser capture) 
microdissection of specific hippocampal subregions and FACS-separation of brain cell 
subpopulations, followed by Taq-Man-based sqRT-PCR and end-point RT-PCR followed 
by SNPplex electrophoresis, the distribution and region/cell specificity of individual 
isoforms could be determined. In addition, it awaits confirmation if activity-induced 
increases of CPEB-3 and -4 mRNA following intraperitoneal kainate injection (Theis et 
al., 2003b) are indeed isoform-specific. This can be tested with the abovementioned 
methods as well. If so, then one could conclude that neuronal activity-induced splicing 
may modulate CPEB expression and properties (e.g. presence or absence of 
phosphorylation sites) in synapse-specific manner. 
7.2 Elucidating the significance of alternative splicing 
The significance of the multitude of splice isoforms of CPEBs in unknown. Herein               
I propose the hypothesis that the presence of the B-domain in CPEB-2 to -4 affects the 
propensity of those proteins for PKA and CaMKII phosphorylation. Both of these kinases 
are critical in synaptic plasticity (Wang et al., 2006; Wu et al., 2006; Anwyl, 2009; 
Lucchesi et al., 2011). CPEBs have been shown to be involved in synaptic plasticity (Wu 
et al., 1998; Alarcon et al., 2004; Aslam et al., 2009; Theis et al., in revision). It is 
therefore reasonable to investigate the putative implication of CPEB splicing and 
phosphorylation in learning and memory. And what about other CPEB isoforms? Do they 
contain regulatory elements? Or maybe interaction domains, binding to translational 
factors or scaffold proteins? Coupling in vitro (interaction studies) and in vivo (mouse 
transgenics and detailed mRNA and protein isoform expression analysis) might shed 
some light on this intriguing phenomenon. 
7.3 Testing mRNA sequence specificity determinants 
In view or the mRNA co-IP results, CPEBs-1 to -4 may have overlapping specificity, as 
shown herein for the CaMKII and -catenin mRNAs. On the other hand, CPEB-3 was 
shown to require mRNA secondary structure for target recognition (Huang et al., 2006). 
Targets of CPEBs differ in the positioning and sequence of the CPE elements present. 
Hypothetically, the position of CPEs with respect to the AAUAAA hexanucleotide (and 
other regulatory elements) may influence CPEB binding and activity (Pique et al., 2008). 
We might be still far away from understanding the molecular mechanism of CPEB 
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function and its determinants. Protein – RNA interaction experiments (using EMSA, 
Surface Plasmon Resonance (SPR), etc.) involving recombinant CPEBs and artificial or 
real mRNA sequences containing CPEs in different (i) number, (ii) composition, (iii) 
relative placement, or (iv) secondary structure might be helpful to shed some light on 
this issue. On the other hand, it is conceivable that CPEBs require binding partners      
(e.g. CPSF) to recognize/bind target mRNA. Altogether, this seems to be the property of 
CPEBs which is the hardest to study, yet without answering this question the molecular 
picture of CPE-dependent polyadenylation will remain incomplete.  
7.4 Studying the function of neuronal CPEBs in vivo 
Transgenic mice overexpressing CPEB isoforms, as well as phosphorylation site 
mutants (constitutively active or kinase-dead) may be used to address the CPEB 
function in vivo. Using electrophysiological methods coupled with two-photon LSCM 
(transgenes are EGFP-tagged), together with the biochemical analysis, it might be 
possible to dissect how translational regulation contributes to local changes of synaptic 
plasticity in brain. How are CPEBs (trans)located and how stimulation affects their 
subcellular localization? Finally, how does the presence or absence of alternatively 
spliced domains and regulatory sites affect the CPEB function? And how this relates to 
the overall morphology (and properties) of the postsynapse? 
7.4.1 Regulation of the GluR2 subunit of the AMPA-R 
Herein I have shown that overexpression of CPEB-3 in forebrain neurons leads to                 
a decrease in GluR2 protein levels (see section 4.2).  This corroborates earlier findings, 
showing increase of GluR2 expression in primary hippocampal neurons, following siRNA-
mediated knock-down of CPEB-3 (Huang et al., 2006). The GluR2 subunit critically 
determines the properties of the AMPA-R function, affecting receptor kinetics, Ca2+ 
permeability, conductance and sensitivity to endogenous polyamines (Isaac et al., 2007). 
Using the patch-clamp technique, one could look at how expression of CPEB-3 and its 
mutants affect AMPA-R expression and Ca2+ permeability. Using NMDA-R agonists and 
antagonists on acute slice preparation, and two-photon LSCM with UV laser based 
glutamate uncaging, one could look in vivo at how synapse morphology and calcium 
transients are affected in CPEB-3 overexpressing mice. Finally, using electrophysiological 
paradigms to induce LTP (repeated TBS trains) one could investigate whether mice 
expressing CPEB-3 and its kinase-dead mutant show altered LTP. 
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7.5 Studying the function of glial CPEBs in vivo 
RNA co-IP revealed mRNA encoding the astrocytic gap junction protein connexin43 as 
a CPEB target.  In addition, glial cells express proteins reported to undergo translational 
regulation in neurons, like -catenin in astrocytes, GluR2 in NG2 glia, or tPA in microglia. 
-catenin is an astrocytic CPEB-1 target (Jones et al., 2008). Herein I showed by RNA        
co-IP, that CPEB-3 binds to the -catenin mRNA as well. Therefore, this mRNA may be 
regulated by other members of CPEB family as well, which is likely to be the case for 
neuronal and glial CPEBs. And what about other CPE-containing astrocytic transcripts? 
The astrocyte-specific GFAP-tTA transgene already serves as a tool to dissect CPEB 
function by overexpression of CPEBs in these cells (Vangoor et al., in preparation). 
Moreover, I have embarked on generating a microglia-specific tTA mouse line (expressing 
tTA driven by the iba1 promoter). These mice are currently under screening and, if 
suitable, may be used to elucidate potential function of CPEBs in the regulation of 
microglial tPA production. 
7.6 CPEBs in the context of temporal lobe epilepsy (TLE) 
Epileptiform activity entails molecular mechanisms similar to those correlated with 
learning and memory, including LTP. Are neuronal or glial CPEBs involved in 
epileptogenesis? Is defective translation one of the reasons for disappearance of 
astrocytes in the epileptic hippocampus? CPEB transcripts are strongly upregulated in 
the hippocampus upon induction of status epilepticus (SE) in mice (Theis et al., 2003b). 
In the intracortical kainate injection model, mice expressing a DN-CPEB1-4 in forebrain 
neurons (Theis et al., in revision) show significantly weaker SE, but develop more 
generalized, recurrent seizures at a later timepoint (Dr. Peter Bedner, unpublished 
data). The mechanism behind this observation is to be disclosed, yet it is probable that 
CPEBs, being to a significant extent implicated in L-LTP formation, have likewise                
a function in TLE pathology. The DN-CPEB1-4 transgene leads to translational 
repression of CPE-containing mRNAs. It is worthwhile to investigate if overexpression of 
CPEB-3 and/or a CPEB-3 constitutively active mutant (S419D) would have the opposite 
effects. 
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